| COMPANY | SYMBOL | PRICE | Shares | Trade Date | UNDERWRITER (S) |
| 10x Genomics, Inc. | TXG | $31.00-$35.00 | 9 million | 9/12/2019 | JP Morgan, Goldman Sachs, BofA Merrill Lynch |
| 1Life Healthcare, Inc. | ONEM | $14.00-$16.00 | 17.5 million | 1/31/2020 | JP Morgan, Morgan Stanley, Allen & Co., Citigroup, Piper Jaffray, Wells Fargo, William Blair |
| 4D Molecular Therapeutics, Inc. | FDMT | $22.00-$23.00 | 8.4 million | 12/11/2020 | Goldman Sachs, BofA Securities, Evercore |
| 89bio, Inc. | ETNB | $15.00-$17.00 | 5.3 million | 11/11/2019 | BofA Merrill Lynch, SVB Leerink, RBC Capital
|
| 908 Devices Inc. | MASS | $18.00-$19.00 | 6.5 million | 12/18/2020 | Cowen, SVB Leerink William Blair, Stifel
|
| AAC Holdings, Inc. | AAC | $12.00-$14.00 | 5 million | 10/2/2014 | William Blair, Raymond James |
| Aardvark Therapeutics, Inc. | AARD | $16.00-$18.00 | 5.88 million | 2/13/2025 | Morgan Stanley, BofA Securities, Cantor, RBC Capital |
| Abcam plc | ABCM | $16.52-$16.52 | 8.95 million ADSs | 10/22/2020 | Morgan Stanley, BofA Securities, SVB Leerink
|
| AbCellera Biologics, Inc. | ABCL | $14.00-$17.00 | 24.15 million | 12/11/2020 | Credit Suisse, Stifel, Berenberg, SVB Leerink, BMO Capital Markets |
| Ablynx NV | ABLX | $17.90-$19.08 | 11.43 million ADSs | 10/25/2017 | BofA Merrill Lynch, J.P. Morgan, Jefferies |
| Abpro Corporation | ABP | Withdrawn | Withdrawn | 5/11/2018 | UBS Investment Bank, Wells Fargo Securities, Nomura, Oppenheimer & Co. |
| AbSci Corporation | ABSI | $15.00-$17.00 | 12.5 million | 7/22/2021 | J.P. Morgan, Credit Suisse, BofA Securities, Cowen, Stifel
|
| AC Immune SA | ACIU | $11.00-$13.00 | 6 million | 9/23/2016 | Credit Suisse, Jefferies, Leerink Partners |
| Accelerated Pharma | ACCP | $4.00-$6.00 | Postponed | 7/21/2017 | Rodman & Renshaw, Joseph Gunnar & Co. |
| Acceleron Pharma | XLRN | $13.00-$15.00 | 5.6 million | 9/19/2013 | Citigroup, Leerink Swann, Piper Jaffray |
| Accolade Inc. | ACCD | $19.00-$21.00 | 10 million | 7/2/2020 | Goldman Sachs, Morgan Stanley, BofA Securities, Piper Sandler, Credit Suisse, William Blair |
| Acelity Holdings | TBD | Withdrawn | TBD | 0/0/0 | J.P. Morgan, Goldman Sachs & Co., BofA Merrill Lynch
|
| ACell, Inc. | ACLL | $14.00-$16.00 | 5 million | 0/0/0 | UBS Investment Bank, Barclays, RBC Capital Markets |
| ACELYRIN, Inc. | SLRN | 30 million | $16.00-$18.00 | 5/5/2023 | Morgan Stanley, Jefferies, TD Cowen, Piper Sandler |
| Achaogen, Inc. | AKAO | $12.00-$14.00 | 6 million | 3/12/2014 | Credit Suisse, Cowen & Co. |
| Achilles Therapeutics Inc. | ACHL | $17.00-$19.00 | 9.75 million ADSs | 3/31/2021 | JP Morgan, BofA Securities, Piper Sandler |
| Aclaris Therapeutics | ACRS | $14.00-$16.00 | 5 million | 10/7/2015 | Jefferies, Citigroup |
| Acrivon Therapeutics, Inc. | ACRV | $16.00-$18.00 | 7.5 million | 11/15/2022 | Jefferies, Cowen, Piper Sandler |
| Acumen Pharmaceuticals | ABOS | $14.00-$16.00 | 10 million | 7/1/2021 | BofA Securities, Credit Suisse, Stifel |
| Acutus Medical Inc | AFIB | $16.00-$18.00 | 8.8 million | 8/6/2020 | J.P. Morgan, BofA Securities, William Blair |
| Adagene Inc. | ADAG | $17.00-$19.00 | 7.4 million ADSs | 2/9/2021 | Goldman Sachs, Morgan Stanley, Jefferies |
| Adagio Therapeutics, Inc. | ADGI | $16.00-$18.00 | 18.2 million | 8/6/2021 | Morgan Stanley, Jefferies, Stifel, Guggenheim Securities |
| Adamas Pharmaceuticals | ADMS | $16.00-$18.00 | 3 million | 4/10/2014 | Credit Suisse, Piper Jaffray |
| AdaptImmune Therapeutics | ADAP | $15.00-$17.00 | 11.25 million | 5/6/2015 | BofA Merrill Lynch, Cowen & Co., Leerink Partners
|
| Adaptive Biotechnologies Corporation | ADPT | $15.00-$17.00 | 15 million | 6/27/2019 | Goldman Sachs & Co., J.P. Morgan, BofA Merrill Lynch |
| ADARx Pharmaceuticals Inc. | ADRX | $15.00-$17.00 | 26.25 million | 9/25/2026 | J.P. Morgan, Morgan Stanley, TD Cowen, UBS Investment Bank, LifeSci Capital |
| ADC Therapeutics SA | ADCT | $16.00-$18.00 | 12.3 million | 5/15/2020 | Morgan Stanley, BofA Merrill Lynch, Cowen |
| Adeptus Health | ADPT | $19.00-$22.00 | 4.9 million | 6/25/2014 | Deutsche Bank Securities, Goldman Sachs & Co., Evercore, Morgan Stanley |
| Adial Pharmaceuticals | ADIL | $5.00-$5.00 | 1.5 million | 7/27/2018 | Joseph Gunnar & Co. |
| ADMA Biologics | ADMA | $8.50-$9.50 | 3.35 million | 10/17/2013 | Oppenheimer & Co., BMO Capital Markets |
| Aduro Biotech | ADRO | $14.00-$16.00 | 7 million | 4/15/2015 | BofA Merrill Lynch, Leerink Partners |
| Advanced Accelerator Applications S.A. | AAAP | $15.00-$17.00 | 4.7 million | 11/11/2015 | Citigroup, Jefferies |
| Advanced Inhalation Therapies, Ltd. | AITPU | $15.00-$15.00 | 333,333 | 0/0/0 | Joseph Gunnar & Co. |
| Aeglea Therapeutics, Inc. | AGLE | $16.00-$18.00 | 5 million | 4/7/2016 | UBS Investment Bank, BMO Capital Markets, Wells Fargo Securities
|
| AEON Biopharma, Inc | AEON | Postponed | Postponed | 10/8/2021 | Wells Fargo, Cantor, Mizuho Securities |
| Aerie Pharmaceuticals | AERI | $12.00-$14.00 | 6.72 million | 10/25/2013 | RBC Capital Markets, Stifel Nicolaus Weisel |
| Aerovate Therapeutics | AVTE | $13.00-$15.00 | 8.7 million | 6/30/2021 | Jefferies, Cowen, Evercore |
| Aesthetic Medical International Holdings Group Limited | AIH | 11.00-$13.00 | 2.5 million ADSs | 10/25/2019 | Cantor, Haitong International, Prime Number Capital |
| Affimed Therapeutics B.V. | AFMD | $11.00-$13.00 | 8 million | 9/12/2014 | Jefferies, Leerink Partners BMO Capital Markets |
| Affinia Therapeutics Inc. | AFTX | Withdrawn | Withdrawn | 0/0/0 | Goldman Sachs, Jefferies, Piper Sandler |
| Agendia N.V. | AGDX | Withdrawn | Withdrawn | 0/0/0 | Goldman Sachs, Citigroup, Cowen, Stifel |
| Agile Therapeutics, Inc. | AGRX | $6.00-$6.00 | 9.2 million | 5/23/2014 | RBC Capital Markets, William Blair |
| Agiliti, Inc | AGTI | $18.00-$20.00 | 26.3 million | 4/23/2021 | BofA Securities, Goldman Sachs, Morgan Stanley, BMO Capital Market, Citigroup, Jefferies, UBS Investment Bank |
| agilon health, Inc. | AGL | $20.00-$23.00 | 46.6 million | 4/15/2021 | JP Morgan, Goldman Sachs, BofA Securities, Deutsche Bank, Wells Fargo |
| Agios Pharmaceuticals | AGIO | $14.00-$16.00 | 5 million | 7/24/2014 | J.P. Morgan, Goldman Sachs |
| AgomAb Therapeutics NV | AGMB | $15.00-$17.00 | 12.5 million | 2/6/2026 | J.P. Morgan, Morgan Stanley, Leerink Partners, Van Lanschot Kempen |
| Aileron Therapeutics, Inc. | ALRN | $15.00-$17.00 | 3.75 million | 6/29/2017 | BofA Merrill Lynch, Jefferies |
| Aimmune Therapeutics, Inc. | AIMT | $14.00-$16.00 | 10 million | 8/6/2015 | BofA Merrill Lynch, Credit Suisse, Piper Jaffray |
| Akcea Therapeutics, Inc. | AKCA | $12.00-$14.00 | 15.63 million | 7/14/2017 | Cowen and Company, Stifel, Wells Fargo Securities |
| Akebia Therapeutics | AKBA | $14.00-$17.00 | 5.88 million | 3/20/2014 | Morgan Stanley, Credit Suisse |
| Akero Therapeutics | AKRO | $14.00-$16.00 | 5.75 million | 6/20/2019 | JP Morgan, Jefferies, Evercore ISI |
| Akouos, Inc. | AKUS | $14.00-$16.00 | 12.5 million | 6/26/2020 | BofA Securities, Cowen, Piper Sandler |
| Akoya Biosciences, Inc. | AKYA | $18.00-$20.00 | 6.6 million | 4/16/2021 | JP Morgan, Morgan Stanley, Piper Sandler, Canaccord Genuity |
| Aktis Oncology, Inc. | AKTS | $16.00-$18.00 | 17.65 million | 1/9/2026 | J.P. Morgan, BofA Securities, Leerink Partners, TD Cowen |
| Alamar Biosciences, Inc. | ALMR | $15.00-$17.00 | 11.25 million | 4/17/2026 | J.P. Morgan, BofA Securities, TD Cowen, Leerink Partners, Stifel |
| Alcobra Ltd. | ADHD | $10.00-$12.00 | 3.125 million | 5/22/2013 | Aegis Capital Corp |
| Alder Biopharmaceuticals | ALDR | $13.00-$15.00 | 7.15 million | 5/8/2014 | Credit Suisse, Leerink Partners. |
| Alector, Inc. | ALEC | $18.00-$20.00 | 9.25 million | 2/7/2019 | Morgan Stanley, BofA Merrill Lynch, Cowen, Barclays |
| Alignment Healthcare, Inc. | ALHC | $17.00-$19.00 | 27.2 million | 3/26/2021 | Goldman Sachs, Morgan Stanley, JP Morgan, BofA Securities, William Blair |
| Aligos Therapeutics, Inc | ALGS | $14.00-$16.00 | 10 million | 10/16/2020 | J.P. Morgan, Jefferies, Piper Sandler |
| Allakos Inc. | ALLK | $15.00-$17.00 | 7.2 million | 7/19/2018 | Goldman Sachs, Jefferies |
| Allena Pharmaceuticals, Inc. | ALNA | $14.00-$16.00 | 5.3 million | 11/2/2017 | Credit Suisse, Jefferies, Cowen & Company |
| Allogene Therapeutics, Inc. | ALLO | $16.00-$18.00 | 18 million | 10/11/2018 | Goldman Sachs & Co, J.P. Morgan, Cowen, Jefferies |
| AlloVir, Inc. | ALVR | $16.00-$18.00 | 16.25 million | 7/30/2020 | Morgan Stanley, JP Morgan, SVB Leerink, Piper Sandler |
| Alpha Teknova, Inc. | TKNO | $14.00-$16.00 | 6 million | 6/25/2021 | Cowen, William Blair
|
| Alto Neuroscience, Inc. | ANRO | $14.00-$16.00 | 8.04 million | 2/2/2024 | Jefferies, TD Cowen, Stifel, William Blair |
| Alumis Inc. | ALMS | $16.00-$18.00 | 13.125 million | 6/28/2024 | Morgan Stanley, Leerink Partners, Cantor, Guggenheim Securities |
| ALX Oncology Holdings Inc. | ALXO | $15.00-$17.00 | 8.5 million | 7/17/2020 | Jefferies, Credit Suisse, Piper Sandler, Cantor |
| Alzheon, Inc. | ALZH | Withdrawn | Withdrawn | 0/0/0 | ThinkEquity, H.C. Wainwright |
| Ambit Biosciences Corporation | AMBI | $8.00-$8.00 | 8.1 million | 5/16/2013 | Citigroup, Leerink Swann |
| Ambrx Biopharma Inc | AMAM | $17.00-$19.00 | 7.0 million ADSs | 6/18/2021 | Goldman Sachs, BofA Securities, Cowen |
| Amedica Corporation | AMDA | $8.00-$10.00 | 3.5 million | 2/13/2014 | JMP Securities |
| American Renal Associates Holdings | ARA | $20.00-$23.00 | 7.5 million | 4/21/2016 | BofA Merrill Lynch, Barclays, Goldman Sachs & Co., Wells Fargo Securities, SunTrust Robinson Humphrey
|
| Amphastar Pharmaceuticals | AMPH | $10.00-$12.00 | 8 million | 6/25/2014 | Jefferies, BMO Capital Markets, Piper Jaffray |
| Amylyx Pharmaceuticals, Inc. | AMLX | $18.00-$20.00 | 10 million | 1/7/2022 | Goldman Sachs, SVB Leerink, Evercore ISI |
| AN2 Therapeutics, Inc. | ANTX | $14.00-$16.00 | 4.6 million | 3/25/2022 | Cowen, SVB Leerink, Evercore ISI
|
| AnaptysBio, Inc. | ANAB | $14.00-$16.00 | 5 million | 1/26/2017 | Credit Suisse, Stifel
|
| Anchiano Therapeutics Ltd. | ANCN | $14.55-$14.55 | 2.65 million ADSs | 2/12/2019 | Oppenheimer & Co. |
| Angion Biomedica Corp. | ANGN | $14.00-$16.00 | 5 million | 2/5/2021 | Cowen, Stifel |
| Annexon, Inc. | ANNX | $15.00-$16.00 | 14.75 million | 7/24/2020 | JP Morgan, BofA Securities, Cowen |
| Apellis Pharmaceuticals | APLS | $13.00-$15.00 | 10.7 million | 11/9/2017 | Citigroup, J.P. Morgan, Evercore ISI |
| Apnimed Inc. | APMD | $14.00-$16.00 | 12 million | 7/31/2026 | BofA Securities, Evercore ISI, Cantor, LifeSci Capital |
| Apogee Therapeutics, Inc. | APGE | $15.00-$17.00 | 17.7 million | 7/14/2023 | Jefferies, TD Cowen, Stifel, Guggenheim Securities |
| Applied Genetic Technologies Corp | AGTC | $13.00-$15.00 | 4.2 million | 3/27/2014 | BMO Capital Markets, Wedbush PacGrow Life Science |
| Applied Molecular Transport Inc. | AMTI | $12.00-$14.00 | 11 million | 6/5/2020 | BofA Securities, Jefferies, SVB Leerink |
| Applied Therapeutics, Inc. | APLT | $14.00-$16.00 | 4 million | 5/14/2019 | Citigroup, Cowen, UBS Investment Bank |
| Aprea Therapeutics, Inc. | APRE | $14.00-$16.00 | 5.7 million | 10/3/2019 | JP Morgan, Morgan Stanley, RBC Capital |
| Apria, Inc. | APR | $19.00-$21.00 | 7.5 million | 2/11/2021 | Citigroup, Goldman Sachs, BofA Securities, JP Morgan |
| Aptinyx, Inc. | APTX | $14.00-$16.00 | 6.4 million | 6/21/2018 | J.P. Morgan, Cowen, Leerink Partners, BMO Capital Markets |
| Aquestive Therapeutics, Inc. | AQST | $14.00-$16.00 | 4.5 million | 7/25/2018 | BMO, RBC |
| Aquinox Pharmaceuticals, Inc. | AQXP | $10.00-$12.00 | 4.2 million | 3/7/2014 | Jefferies, Cowen & Co. |
| Aratana Therapeutics | PETX | $11.00-$13.00 | 5.75 million | 6/27/2013 | Stifel, Lazard Capital |
| Arcadia Biosciences, Inc. | RKDA | $13.00-$15.00 | 8.2 million | 5/15/2015 | Credit Suisse, J.P. Morgan, Piper Jaffray |
| Arcellx, Inc. | ACLX | $15.00-$17.00 | 8.25 million | 2/4/2022 | BofA Securities, SVB Leerink, Barclays, William Blair |
| ArcherDX, Inc. | RCHR | Withdrawn | Withdrawn | 0/0/0 | JP Morgan, BofA Securities, Stifel, Evercore ISI |
| Arcus Biosciences, Inc. | RCUS | $13.00-$15.00 | 8 million | 3/15/2018 | Citigroup, Goldman Sachs & Co., Leerink Partners |
| Arcutis Biotherapeutics Inc. | ARQT | $15.00-$17.00 | 9.6 million | 1/31/2020 | Goldman Sachs, Cowen, Guggenheim Securities |
| Ardelyx Inc., | ARDX | $13.00-$15.00 | 4.3 million | 6/19/2014 | Citigroup, Leerink Partners |
| Ardent Health Partners, Inc. | ARDT | $20.00-$22.00 | 12 million | 7/18/2024 | J.P. Morgan, BofA Securities, Morgan Stanley, Stephens Inc, Citigroup, Leerink Partners, RBC Capital Markets, Truist Securities, Mizuho, Capital One Securities, Loop Capital Markets |
| Argenx N.V. | ARGX | Last Trade $18.18 | 5.0 million ADS | 5/18/2017 | Cowen and Company, Piper Jaffray |
| Argos Therapeutics | ARGS | $13.00-$15.00 | 5.63 million | 2/7/2014 | Piper Jaffray, Stifel, JMP Securities |
| Aridis Pharmaceuticals, Inc. | ARDS | $13.00-$15.00 | 2 million | 8/14/2018 | Cantor, Maxim Group |
| ARMO BioSciences, Inc. | ARMO | $14.00-$16.00 | 7.5 million | 1/26/2018 | Jefferies, Leerink, BMO Capital Markets |
| Arog Pharmaceuticals, Inc. | AROG | Withdrawn | Withdrawn | 0/0/0 | Citigroup, RBC Capital, Nomura |
| ArriVent BioPharma Inc | AVBP | $17.00-$19.00 | 9.7 million | 1/26/2024 | Goldman Sachs, Jefferies, Citigroup |
| Arsanis, Inc. | ASNS | $15.00-$17.00 | 4 million | 11/16/2017 | Citigroup, Cowen, Piper Jaffray |
| Artiva Biotherapeutics Inc. | ARTV | $14.00-$16.00 | 13.9 million | 7/19/2024 | Jefferies, TD Cowen, Cantor
|
| Arvinas, Inc | ARVN | $14.00-$16.00 | 7.5 million | 9/27/2018 | Goldman Sachs, Citigroup, Piper Jaffray |
| Ascendis Pharma A/S | ASND | $16.00-$18.00 | 6 million | 1/28/2015 | BofA Merrill Lynch, Leerink Partners, Wells Fargo Securities |
| ASLAN Pharmaceuticals Limited | ASLN | $8.05-$8.05 | 6 million ADSs | 5/4/2018 | Leerink Partners, Piper Jaffray |
| Aspen Neuroscience Inc. | ASPE | TBD | TBD | 0/0/0 | Leerink Partners, Piper Sandler, Stifel, UBS Investment Bank, Oppenheimer & Co. |
| ATAI Life Sciences B.V. | ATAI | $13.00-$15.00 | 15 million | 6/18/2021 | Credit Suisse, Citigroup, Cowen, Berenberg |
| Atara Biotherapeutics, Inc. | ATRA | $14.00-$16.00 | 5 million | 10/16/2014 | Goldman Sachs & Co., Citigroup
|
| Atea Pharmaceuticals, Inc. | AVIR | $22.00-$24.00 | 12.5 million | 10/30/2020 | J.P. Morgan, Morgan Stanley, Evercore ISI, William Blair |
| Athenex, Inc. | ATNX | $11.00-$13.00 | 6 million | 6/14/2017 | Credit Suisse, Deutsche Bank Securities, J.P. Morgan |
| Athira Pharma, Inc. | ATHA | $15.00-$17.00 | 12 million | 9/18/2020 | Goldman Sachs, Jefferies, Stifel |
| Atreca Inc | BCEL | $16.00-$18.00 | 7.4 million | 6/20/2019 | Cowen, Evercore ISI, Stifel
|
| Attovia Therapeutics, Inc. | ATTO | $17.00-$17.00 | 17 million | 8/5/2026 | Morgan Stanley, Leerink Partners, Citigroup, RBC Capital Markets, LifeSci Capital |
| aTyr Pharma | LIFE | $13.00-$15.00 | 5.4 million | 5/7/2015 | J.P. Morgan, Citigroup
|
| Audentes Therapeutics, Inc. | BOLD | $14.00-$16.00 | 5 million | 7/20/2016 | BofA Merrill Lynch, Cowen & Co., Piper Jaffray |
| Auna S.A.A. | AUNA | $13.00-$15.00 | 30 million | 3/22/2024 | Morgan Stanley, JP Morgan, BTG Pactual, Santander, Citigroup, HSBC |
| Aura Biosciences, Inc. | AURA | $14.00-$16.00 | 5.4 million | 10/29/2021 | Cowen, SVB Leerink, Evercore |
| Aurion Biotech, Inc. | AURN | Withdrawn | Withdrawn | 0/0/0 | J.P. Morgan, BofA Securities, Piper Sandler, Wells Fargo |
| Auris Medical Holding AG | EARS | $10.00-$12.00 | 9.4 million | 8/6/2014 | Jefferies, Leerink Partners |
| Auspex Pharmaceuticals | ASPX | $10.00-$12.00 | 7 million | 2/5/2014 | Stifel, BMO Capital Markets |
| Autolus Therapeutics Limited | AUTL | $15.00-$17.00 | 8.8 million | 6/22/2018 | Goldman Sachs & Co., Jefferies |
| Avadim Health Inc. | AHI | $14.00-$16.00 | 5 million | 0/0/0 | Raymond James, SunTrust Robinson Humphrey |
| Avalanche Biotechnologies, Inc. | AAVL | $13.00-$15.00 | 5.4 million | 7/31/2014 | Jefferies, Cowen & Co., Piper Jaffray |
| Avalyn Pharma Inc. | AVLN | $16.00-$18.00 | 16.7 million | 4/30/2026 | Morgan Stanley, Jefferies, Evercore ISI, Guggenheim Securities |
| Avantor, Inc. | AVTR | $18.00-$21.00 | 207 million | 5/17/2019 | Goldman Sachs, JP Morgan, BofA Merrill Lynch, Barclays, Jefferies |
| Aveanna Healthcare Holdings Inc. | AVAH | $12.00-$13.00 | 38.3 million | 4/29/2021 | Barclays, JP Morgan, BMO Capital, Credit Suisse, BofA Securities, Deutsche Bank, Jefferies, RBC Capital, Truist Securities |
| Avedro, Inc | AVDR | $14.00-$16.00 | 5 million | 2/14/2019 | BofA Merrill Lynch, JP Morgan, Cowen, Guggenheim Securities, SVB Leerink |
| Avenue Therapeutics, Inc. | ATXI | $5.00-$7.00 | 5.5 million | 6/27/2017 | Oppenheimer & Co. |
| AveXis, Inc. | AVXS | $19.00-$21.00 | 4.75 million | 2/11/2016 | Goldman Sachs & Co., Jefferies
|
| Avidity Biosciences, Inc. | RNA | $14.00-$16.00 | 14.4 million | 6/12/2020 | Cowen, SVB Leerink, Credit Suisse, Wells Fargo Securities |
| Avinger, Inc. | AVGR | $12.00-$14.00 | 5 million | 1/30/2015 | Canaccord Genuity, Cowen & Co.
|
| AVROBIO, Inc. | AVRO | $16.00-$18.00 | 5.2 million | 6/21/2018 | Morgan Stanley, Cowen, Wells Fargo Securities |
| Axcella Health Inc. | AXLA | $20.00-$22.00 | 3.6 million | 5/9/2019 | Goldman Sachs, JP Morgan, SVB Leerink |
| Axonics Modulation Technologies, Inc. | AXNX | $14.00-$16.00 | 8.0 million | 10/31/2018 | BofA Merrill Lynch, Morgan Stanley |
| Axovant Sciences, Ltd. | AXON | $13.00-$15.00 | 21 million | 6/11/2015 | Jefferies, Evercore ISI, RBC Capital Markets |
| Axsome Therapeutics | AXSM | $11.00-$13.00 | 5.6 million | 11/19/2015 | Ladenburg Thalmann |
| Ayala Pharmaceuticals, Inc. | AYLA | $14.00-$16.00 | 3.7 million | 5/8/2020 | Citigroup, Jefferies |
| Aziyo Biologics, Inc. | AZYO | $16.00-$18.00 | 2.9 million | 10/8/2020 | Piper Sandler, Cowen |
| AzurRx, Inc. | AZRX | $6.00-$8.00 | 960 thousand | 10/11/2016 | WallachBeth Capital, Network 1 Financial |
| Bambusa Therapeutics, Inc. | BBTX | TBD | TBD | 0/0/0 | BofA Securities, Evercore ISI, UBS Investment Bank, Cantor |
| Bausch + Lomb Corporation | BLCO | $21.00-$24.00 | 35 million | 5/6/2022 | Morgan Stanley, Goldman Sachs, Citigroup, JP Morgan, Barclays, BofA Securities, Guggenheim Securities, Jefferies, Evercore, Wells Fargo, Deutsche Bank |
| Beam Therapeutics, Inc. | BEAM | $15.00-$17.00 | 10.6 million | 2/6/2020 | JP Morgan, Jefferies, Barclays |
| BeiGene, Ltd. | BGNE | $15.00-$17.00 | 6.6 million | 2/3/2016 | Goldman Sachs & Co., Morgan Stanley, Cowen & Co. |
| Bellerophon Therapeutics | BLPH | $14.00-$16.00 | 4 million | 2/13/2015 | Leerink Partners, Cowen & Co. |
| Bellicum Pharmaceuticals | BLCM | $15.00-$17.00 | 7.35 million | 12/18/2014 | Jefferies, Citigroup, Piper Jaffray |
| Berkeley Lights, Inc. | BLI | $19.00-$20.00 | 8.1 million | 7/17/2020 | JP Morgan, Morgan Stanley, Cowen |
| Beta Bionic, Inc. | BBNX | $16.00-$17.00 | 12 million | 1/30/2025 | BofA Securities, Piper Sandler, Leerink Partners |
| BeyondSpring Inc. | BYSI | $20.00-$22.00 | 174K | 3/9/2017 | Rodman & Renshaw |
| Bicara Therapeutics, Inc. | BCAX | $16.00-$18.00 | 17.5 million | 9/13/2024 | Morgan Stanley, TD Cowen, Cantor, Stifel |
| Bicycle Therapeutics plc | BCYC | $14.00-$16.00 | 4.33 million | 5/23/2019 | Goldman Sachs, Jefferies, Piper Jaffray |
| BillionToOne, Inc. | BLLN | $49.00-$55.00 | 4.55 million | 11/6/2025 | J.P. Morgan, Piper Sandler, Jefferies, William Blair, Stifel, Wells Fargo Securities, BTIG |
| Bind Therapeutics, Inc. | BIND | $14.00-$16.00 | 4.7 million | 9/20/2013 | Credit Suisse, Cowen & Co. |
| Bio Blast Pharma Ltd. | ORPN | $11.00-$13.00 | 3.2 million | 7/31/2014 | Oppenheimer & Co., Roth Capital Partners |
| BioAge Labs Inc. | BIOA | $17.00-$19.00 | 11 million | 9/26/2024 | Goldman Sachs, Morgan Stanley, Jefferies, Citigroup |
| BioAtla, Inc. | BCAB | $15.00-$17.00 | 10.5 million | 12/16/2020 | J.P. Morgan, Jefferies, Credit Suisse |
| Biodesix, Inc. | BDSX | $17.00-$19.00 | 4 million | 10/28/2020 | Morgan Stanley, William Blair
|
| Biofrontera AG | BFRA | $11.00-$13.00 | 1.21 million | 2/14/2018 | Benchmark |
| Biohaven Pharmaceutical Holding Company Ltd. | BHVN | $14.00-$16.00 | 9.9 million | 5/4/2017 | Morgan Stanley, Piper Jaffray, Barclays |
| Biomea Fusion, Inc. | BMEA | $15.00-$17.00 | 9 million | 4/16/2021 | JP Morgan, Jefferies, Piper Sandler
|
| Bionano Genomics, Inc. | BNGOU | $6.00-$7.00 | 3.36 million units | 8/21/2018 | Roth Capital, Maxim Group |
| BioNTech SE | BNTX | $18.00-$20.00 | 10 million ADSs | 10/10/2019 | JP Morgan, BofA Merrill Lynch, UBS Investment Bank, SVB Leerink |
| Bioventus Inc. | BVS | $16.00-$18.00 | 8 million | 2/11/2021 | Morgan Stanley, JP Morgan, Goldman Sachs |
| BioXcel Therapeutics, Inc. | BTAI | $11.00-$13.00 | 5.4 million | 3/8/2018 | Barclays, UBS Investment Bank, BMO Capital Markets
|
| Black Diamond Therapeutics, Inc. | BDTX | $16.00-$18.00 | 10.6 million | 1/30/2020 | JP Morgan, Jefferies, Cowen |
| BlossomHill Therapeutics, Inc. | BLSM | $15.00-$17.00 | 9.375 million | 8/7/2026 | J.P. Morgan, Leerink Partners, Guggenheim Securities, LifeSci Capital, H.C. Wainwright |
| bluebird bio, Inc. | BLUE | $14.00-$16.00 | 5.9 million | 6/19/2013 | J.P. Morgan, BofA Merrill Lynch
|
| Blueprint Medicines Corporation | BPMC | $15.00-$17.00 | 8.15 million | 4/30/2015 | Goldman Sachs & Co., Cowen & Co. |
| Bolt Therapeutics, Inc. | BOLT | $18.00-$19.00 | 11.5 million | 2/5/2021 | Morgan Stanley, SVB Leerink, Stifel, Guggenheim Securities |
| Boundless Bio Inc | BOLD | $15.00-$17.00 | 6.25 million | 3/28/2024 | Goldman Sachs, Leerink Partners, Piper Sandler, Guggenheim Securities |
| Braveheart Bio Inc. | BRVE | $15.00-$17.00 | 21.25 million | 8/6/2026 | Goldman Sachs, Jefferies, TD Cowen, Stifel, Cantor |
| BridgeBio Pharma, Inc. | BBIO | $14.00-$16.00 | 20.5 million | 6/27/2019 | J.P. Morgan, Goldman Sachs & Co, Jefferies, SVB Leerink, KKR |
| Bright Health Group Inc. | BHG | $20.00-$23.00 | 51.35 million | 6/24/2021 | JP Morgan, Goldman Sachs, Morgan Stanley Barclays, BofA Securities, Citigroup, Piper Sandler |
| BrightSpring Health Services, Inc. | BTSG | $15.00-$18.00 | 53.3 million | 1/26/2024 | Goldman Sachs, KKR, Jefferies, Morgan Stanley, UBS, BofA Securities, Leerink Partners, Wells Fargo, Deutsche Bank, HSBC, Mizuho, BMO Capital Markets, Loop Capital Markets |
| Burning Rock Biotech Limited | BNR | $13.50-$15.50 | 13.5 million ADSs | 6/12/2020 | Morgan Stanley, BofA Securities, Cowen |
| C4 Therapeutics, Inc. | CCCC | $16.00-$18.00 | 9.6 million | 10/2/2020 | Jefferies, Evercore ISI, BMO Capital Markets, UBS Investment Bank
|
| Cabaletta Bio, Inc. | CABA | $14.00-$16.00 | 6.8 million | 10/25/2019 | Morgan Stanley, Cowen, Evercore ISI |
| Calithera Biosciences | CALA | $13.00-$15.00 | 8 million | 10/2/2014 | Citigroup, Leerink Partners |
| Calliditas Therapeutics AB | CALT | $19.77-$19.77 | 4.1 million ADSs | 6/5/2020 | Citigroup, Jefferies, Stifel |
| Calyxt, Inc. | CLXT | $15.00-$18.00 | 7 million | 7/20/2017 | Citigroup, Jefferies, Wells Fargo Securities |
| CAMP4 Therapeutics Corporation | CAMP | $14.00-$16.00 | 6.82 million | 10/11/2024 | J.P. Morgan, Leerink Partners, Piper Sandler, William Blair
|
| Cancer Genetics | CGIX | $10.00-$12.00 | 600 Thousand | 4/5/2013 | Aegis Capital Corp, Feltl & Co. |
| Cancer Prevention Pharmaceuticals | CPP | Withdrawn | 1.25 million | 0/0/0 | Aegis Capital |
| Candel Therapeutics, Inc. | CADL | $8.00-$8.00 | 9 million | 7/27/2021 | Jefferies, Credit Suisse, BMO Capital Markets, UBS Investment Bank |
| Candela Medical, Inc. | CDLA | Postponed | Postponed | 10/28/2021 | BofA Securities, Goldman Sachs, Barclays, Baird, Canaccord Genuity, Stifel |
| Capnia, Inc. | CAPN | $6.50-$8.50 | 1.65 million | 11/13/2014 | Maxim Group LLC |
| Cara Therapeutics | CARA | $11.00-$13.00 | 5 million | 1/31/2014 | Stifel, Piper Jaffray |
| Carbylan Therapeutics | CBYL | $12.00-$14.00 | 13 million | 4/9/2015 | Leerink Partners |
| Cardiva Medical Inc | TBD | Withdrawn | Withdrawn | 1/0/2021 | J.P. Morgan, BofA Securities, Canaccord Genuity, Stifel |
| CareDx Inc., | CDNA | $15.00-$17.00 | 4 million | 7/17/2014 | Piper Jaffray, Leerink Partners |
| CARGO Therapeutics, Inc. | CRGX | $15.00-$17.00 | 18.75 million | 11/10/2023 | J.P. Morgan, Jefferies, TD Cowen, Truist Securities |
| Caribou Biosciences, Inc. | CRBU | $14.00-$16.00 | 19 million | 7/23/2021 | BofA Securities, Citigroup, SVB Leerink
|
| Caris Life Sciences, Inc. | CAI | $19.00-$20.00 | 23.5 million | 6/18/2025 | BofA Securities, J.P. Morgan, Goldman Sachs & Co., Citigroup, TD Cowen, Evercore ISI, Guggenheim Securities, BTIG, Wolfe | Nomura Alliance |
| Carlsmed, Inc. | CARL | $14.00-$16.00 | 6.7 million | 7/23/2025 | BofA Securities, Goldman Sachs, Piper Sandler |
| Carmot Therapeutics Inc. | CRMO | Withdrawn | Withdrawn | 0/0/0 | J.P. Morgan, BofA Securities, Piper Sandler, Guggenheim |
| Castle Biosciences, Inc. | CSTL | $14.00-$16.00 | 4 million | 7/25/2019 | SVB Leerink, Baird |
| Castle Creek Biosciences, Inc. | CCBS | TBD | TBD | 0/0/0 | Citigroup, Piper Sandler, Barclays |
| Catabasis Pharmaceuticals | CATB | $13.00-$15.00 | 5 million | 6/25/2015 | Citigroup, Cowen & Co. |
| Catalent, Inc. | CTLT | $19.00-$22.00 | 42.5 million | 7/31/2014 | Morgan Stanley, J.P. Morgan |
| Celcuity LLC | CELC | $8.00-$10.00 | 2.4 million | 9/20/2017 | Craig Hallum Capital Group |
| Celladon Corporation | CLDN | $14.00-$16.00 | 5 million | 1/30/2013 | J.P. Morgan, Barclays |
| Cellular Dynamics International | ICEL | $12.00-$14.00 | 3.9 million | 7/25/2013 | J.P. Morgan |
| Cempra Holdings | CEMP | $11.00-$13.00 | 6 million | 2/3/2012 | Stifel Nicolaus Weisel, Leerink Swann, Cowen and Company |
| Centessa Pharmaceuticals plc. | CNTA | $18.00-$20.00 | 16.5 million ADSs | 5/28/2021 | Morgan Stanley, Goldman Sachs, Jefferies, Evercore ISI |
| Centinel Spine Holdco, Inc. | CNTL | TBD | TBD | 0/0/0 | Morgan Stanley, Goldman Sachs, Piper Sandler, Canaccord Genuity, BTIG |
| Centogene N.V. | CNTG | $14.00-$16.00 | 4 million | 11/7/2019 | SVB Leerink, Evercore ISI |
| Centrexion Therapeutics Corporation | CNTX | Postponed | Postponed | 0/0/0 | BofA Merrill Lynch, Leerink Partners, Evercore ISI |
| Century Therapeutics, Inc | IPSC | $18.00-$20.00 | 10.6 million | 6/18/2021 | JP Morgan, BofA Securities, SVB Leerink, Piper Sandler |
| Cerecor, Inc. | CERC | $6.00-$7.00 | 4 million | 10/15/2015 | Maxim Group LLC |
| CeriBell, Inc. | CBLL | $14.00-$16.00 | 10.6 million | 10/11/2024 | BofA Securities, J.P. Morgan |
| Certara, Inc. | CERT | $19.00-$22.00 | 29.05 million | 12/11/2020 | Jefferies, Morgan Stanley, BofA Securities, Credit Suisse, Barclays, William Blair |
| Cerulean Pharma | CERU | $11.00-$13.00 | 8.5 million | 4/10/2014 | Leerink Partners |
| CG Oncology, Inc. | CGON | $16.00-$18.00 | 20 million | 1/25/2024 | Morgan Stanley, Goldman Sachs, Cantor |
| Change Healthcare Inc. | CHNG | $16.00-$19.00 | 42.9 million | 6/27/2019 | Barclays, Goldman Sachs, JP Morgan, BofA Merrill Lynch, Citigroup, Credit Suisse, Deutsche Bank Securities, Morgan Stanley. RBC Capital Markets |
| Check-Cap Ltd. | CHEKU | $10.00-$12.00 | 2 million | 2/19/2015 | Chardan Capital Markets, LLC, Maxim Group LLC
|
| Checkmate Pharmaceuticals, Inc. | CMPI | $14.00-$16.00 | 5 million | 8/7/2020 | BofA Securities, Jefferies, BMO Capital Markets |
| ChemoCentryx | CCXI | $14.00-$16.00 | 4.5 million | 2/23/2012 | J.P. Morgan, Citigroup |
| Chiasma, Inc. | CHMA | $13.00-$15.00 | 6.36 million | 7/16/2015 | Barclays, Cowen & Co. |
| Chimerix | CMRX | $13.00-$15.00 | 7.32 million | 4/11/2013 | Morgan Stanley, J.P. Morgan |
| Cibus Ltd. | CBUS | Postponed | Postponed | 0/0/0 | Morgan Stanley, BofA Merrill Lynch, Piper Jaffray |
| Cidara Therapeutics | CDTX | $14.00-$16.00 | 4.8 million | 4/15/2015 | Jefferies, Leerink Partners |
| CinCor Pharma, Inc. | CINC | $15.00-$17.00 | 12.1 million | 1/7/2022 | Morgan Stanley, Jefferies, Evercore ISI |
| Cirius Therapeutics, Inc. | CSTX | Withdrawn | Withdrawn | 0/0/0 | Citigroup, Credit Suisse |
| City Therapeutics, Inc. | CTY | $17.00-$19.00 | 11.1 million | 10/16/2026 | Goldman Sachs, Jefferies, Stifel, Oppenheimer |
| Civitas Solutions, Inc. | CIVI | $20.00-$23.00 | 11.7 million | 9/17/2014 | Barclays, Jefferies, BofA Merrill Lynch, UBS Investment Bank |
| Clearside Biomedical | CLSD | $7.00-$7.00 | 7.2 million | 6/2/2016 | Cowen & Co., Stifel |
| Clementia Pharmaceuticals | CMTA | $13.00-$15.00 | 8 million | 8/2/2017 | Morgan Stanley, Leerink Partners |
| Clovis Oncology | CLVS | $13.00-$15.00 | 9.3 million | 11/16/2011 | J.P. Morgan, Credit Suisse |
| Co-Diagnostics, Inc. | CODX | $6.35-$6.75 | 1.2 million | 7/12/2017 | WallachBeth Capital, LLC, Network 1 Financial Securities |
| Codex DNA, Inc. | DNAY | $14.00-$16.00 | 6.7 million | 6/18/2021 | Jefferies, Cowen, KeyBanc Capital
|
| Codiak BioSciences, Inc. | CDAK | $14.00-$16.00 | 5.5 million | 10/14/2020 | Goldman Sachs, Evercore ISI, William Blair |
| Cognition Therapeutics, Inc. | CGTX | $11.00-$13.00 | 3.77 million | 10/8/2021 | B Riley, Oppenheimer |
| Coherus BioSciences, Inc. | CHRS | $12.00-$15.00 | 6.3 million | 11/6/2014 | J.P. Morgan, Credit Suisse |
| Collegium Pharmaceutical | COLL | $12.00-$14.00 | 5.8 million | 5/7/2015 | Jefferies, Piper Jaffray |
| Colucid Pharmaceuticals | CLCD | $13.00-$15.00 | 5.5 million | 5/6/2015 | Piper Jaffray, Stifel |
| Community Healthcare Trust | CHCT | $19.00-$21.00 | 6.25 million | 5/21/2015 | Sandler O' Neill + Partners LP, Evercore ISI, SunTrust Robinson Humphrey |
| COMPASS Pathways plc | CMPS | $14.00-$16.00 | 7.5 million | 9/18/2020 | Cowen, Evercore ISI, Berenberg |
| Compass Therapeutics, Inc. | CMPX | Postponed | Postponed | 10/13/2020 | Citigroup, Credit Suisse, Stifel |
| Conatus Pharmaceuticals | CNAT | $10.00-$12.00 | 6 million | 7/25/2013 | Stifel Nicolaus Weisel, Piper Jaffray |
| Concentra Group Holdings Parent, Inc. | CON | $23.00-$26.00 | 22.5 million | 7/25/2024 | J.P. Morgan, Goldman Sachs, BofA Securities, Deutsche Bank, Wells Fargo Securities, Mizuho, RBC Capital, Truist |
| Concert Pharmaceuticals, Inc. | CNCE | $12.00-$14.00 | 6 million | 2/13/2014 | UBS Investment Bank, Wells Fargo Securities |
| ConforMIS, Inc. | CFMS | $14.00-$16.00 | 9 million | 7/1/2015 | J.P. Morgan, Deutsche Bank Securities |
| Connect Biopharma Holdings Limited | CNTB | $15.00-$17.00 | 11.25 million ADSs | 3/19/2021 | Jefferies, SVB Leerink, Piper Sandler, CICC |
| Constellation Pharmaceuticals, Inc. | CNST | $14.00-$16.00 | 4 million | 7/19/2018 | J.P. Morgan, Jefferies, BMO Capital Markets
|
| Contineum Therapeutics, Inc. | CTNM | $16.00-$18.00 | 6.875 million | 4/5/2024 | Goldman Sachs, Morgan Stanley, Stifel, RBC Capital |
| Convey Holding Parent, Inc. | CNVY | $14.00-$16.00 | 13.3 million | 6/16/2021 | Goldman Sachs, JP Morgan, Barclays
|
| Corium International, Inc. | CORI | $10.00-$12.00 | 6.5 million | 4/3/2014 | Jefferies, Leerink Partners |
| Cortexyme, Inc. | CRTX | $16.00-$18.00 | 4.4 million | 5/9/2019 | BofA Merrill Lynch, Credit Suisse |
| Corvus Pharmaceuticals | CRVS | $15.00-$17.00 | 4.7 million | 3/23/2016 | Credit Suisse, Cowen & Co., Guggenheim Securities |
| Crinetics Pharmaceuticals, Inc. | CRNX | $15.00-$17.00 | 6.0 million | 7/18/2018 | J.P. Morgan, Leerink Partners, Piper Jaffray |
| CRISPR Therapeutics | CRSP | $15.00-$17.00 | 4 million | 10/19/2016 | Citigroup, Piper Jaffray, Barclays |
| Cue Biopharma, Inc. | CUE | $7.50-$7.50 | 8.8 million | 1/2/2018 | MDB Capital, Feltl and Company |
| Cue Health Inc. | HLTH | $15.00-$17.00 | 12.5 million | 9/24/2021 | Goldman Sachs, Morgan Stanley, Cowen |
| Cullinan Management, Inc. | CGEM | $19.00-$20.00 | 11.9 million | 1/8/2021 | Morgan Stanley, SVB Leerink, Evercore ISI |
| CureVac B.V. | CVAC | $14.00-$16.00 | 13.3 million | 8/14/2020 | BofA Securities, Jefferies, Credit Suisse |
| CVRx, Inc. | CVRX | $15.00-$17.00 | 7 million | 6/30/2021 | JP Morgan, Piper Sandler, William Blair |
| Cyteir Therapeutics, Inc. | CYT | $16.00-$18.00 | 7.4 million | 6/18/2021 | JP Morgan, Morgan Stanley, BofA Securities |
| Cytek Biosciences, Inc. | CTKB | $16.00-$18.00 | 16.7 million | 7/23/2021 | Morgan Stanley, Goldman Sachs, Piper Sandler, Cowen
|
| CytomX Therapeutics | CTMX | $14.00-$16.00 | 6.7 million | 10/8/2015 | BofA Merrill Lynch, Jefferies, Cowen & Co. |
| Day One Biopharmaceuticals Holding Company, LLC | DAWN | $14.00-$16.00 | 10 million | 5/27/2021 | JP Morgan, Cowen, Piper Sandler |
| Decibel Therapeutics, Inc. | DBTX | $16.00-$18.00 | 7.062 million | 2/12/2021 | Citigroup, SVB Leerink, BMO Capital Markets, Barclays |
| Decipher Biosciences, Inc. | DECI | Withdrawn | Withdrawn | 0/0/0 | Evercore ISI, Wells Fargo |
| Deciphera Pharmaceuticals | DCPH | $15.00-$17.00 | 7.5 million | 9/28/2017 | J.P. Morgan, Piper Jaffray |
| Definitive Healthcare Corp | DH | $24.00-$26.00 | 15.6 million | 9/15/2021 | Goldman Sachs, J.P. Morgan, Morgan Stanley, Barclays, Credit Suisse, Deutsche Bank Securities |
| Denali Therapeutics Inc | DNLI | $17.00-$19.00 | 13.88 million | 12/8/2017 | Goldman Sachs, J.P. Morgan, Morgan Stanley |
| Dermavant Sciences, Inc. | DRMT | Postponed | Postponed | 6/20/2019 | Jefferies, SVB Leerink, Guggenheim Securities |
| Dermira, Inc. | DERM | $14.00-$16.00 | 7.8 million | 10/3/2014 | Citigroup, Leerink Partners
|
| Design Therapeutics, Inc | DSGN | $18.00-$20.00 | 12 million | 3/26/2021 | Goldman Sachs, SVB Leerink, Piper Sandler |
| Dicerna Pharmaceuticals, Inc. | DRNA | $11.00-$13.00 | 6 million | 1/30/2014 | Jefferies, Leerink Swann, Stifel |
| Dimension Therapeutics | DMTX | $14.00-$16.00 | 5.5 million | 10/22/2015 | Goldman Sachs & Co., Citigroup, Wells Fargo Securities
|
| Dipexium Pharmaceuticals, LLC | DPRX | $12.00-$14.00 | 2.75 million | 3/13/2014 | Oppenheimer & Co., Feltl & Co. |
| Diplomat Pharmacy | DPLO | $14.00-$16.00 | 13.33 million | 10/10/2014 | Credit Suisse, Morgan Stanley |
| Dova Pharmaceuticals, Inc. | DOVA | $15.00-$17.00 | 4.41 million | 6/29/2017 | J.P. Morgan, Jefferies, Leerink Partners |
| Doximity, Inc. | DOCS | $20.00-$23.00 | 23.3 million | 6/24/2021 | Morgan Stanley, Goldman Sachs, JP Morgan |
| Durata Therapeutics, Inc. | DRTX | $11.00-$13.00 | 7.5 million | 7/19/2012 | BofA Merrill Lynch, Credit Suisse |
| Dynacure S.A. | DYCU | Withdrawn | Withdrawn | 7/16/2021 | J.P. Morgan, BofA Securities, Wells Fargo Securities |
| Dyne Therapeutics Inc | DYN | $16.00-$18.00 | 12.25 million | 9/17/2020 | J.P. Morgan, Jefferies, Piper Sandler, Stifel |
| Eagle Pharmaceuticals | EGRX | $14.00-$16.00 | 3.33 million | 2/12/2014 | Piper Jaffray, William Blair |
| Eargo, Inc. | EAR | $14.00-$16.00 | 7.8 miliion | 10/16/2020 | J.P. Morgan, BofA Securities |
| Edge Therapeutics | EDGE | $14.00-$16.00 | 7.3 million | 10/1/2015 | Leerink Partners, Credit Suisse |
| Edgewise Therapeutics, Inc. | EWTX | $14.00-$16.00 | 11 million | 3/26/2021 | JP Morgan, Goldman Sachs, SVB Leerink |
| Editas Medicine, Inc. | EDIT | $16.00-$18.00 | 5.9 million | 2/3/2016 | Morgan Stanley, J.P. Morgan |
| Egalet | EGLT | $11.00-$13.00 | 4.2 million | 2/6/2014 | Stifel, JMP Securities |
| Eidos Therapeutics, Inc. | EIDX | $15.00-$17.00 | 6.3 million | 6/20/2018 | J.P. Morgan, BofA Merrill Lynch |
| Eikon Therapeutics, Inc. | EIKN | $16.00-$18.00 | 21.2 million | 2/5/2026 | J.P. Morgan, Morgan Stanley, BofA Securities, Cantor |
| Elanco Animal Health Inc. | ELAN | $20.00-$23.00 | 63 million | 9/20/2018 | Goldman Sachs, J.P. Morgan, Morgan Stanley |
| Electra Therapeutics, Inc. | ETRA | $14.00-$16.00 | 23.3 million | 9/18/2026 | Jefferies, TD Cowen, Evercore ISI, Cantor |
| ElectroCore LLC | ECOR | $14.00-$16.00 | 4.33 million | 6/21/2018 | Evercore ISI, JMP Securities, BTIG |
| Elevation Oncology, Inc. | ELEV | $15.00-$17.00 | 6.25 million | 6/25/2021 | JP Morgan, Cowen, SVB Leerink
|
| Eleven Biotherapeutics | EBIO | $13.00-$15.00 | 5 million | 2/6/2014 | Citigroup, Cowen & Co., Leerink Swann |
| Eliem Therapeutics, Inc. | ELYM | $12.50-$12.50 | 6.4 million | 8/10/2021 | SVB Leerink, Evercore ISI, Stifel, Guggenheim Securities |
| Ellipse Technologies, Inc. | MGEC | TBD | TBD | 0/0/0 | Piper Jaffray, William Blair, Canaccord Genuity
|
| Enanta Pharmaceuticals | ENTA | $14.00-$16.00 | 4 million | 3/21/2013 | J.P. Morgan, Credit Suisse |
| EndoChoice Holdings | GI | $15.00-$17.00 | 6.35 million | 6/5/2015 | J.P. Morgan, BofA Merrill Lynch |
| Endostim, Inc. | STIM | TBD | 3.2 million | 0/0/0 | Wedbush PacGrow Life Sciences
|
| Endra Life Sciences | NDRAU | $5.00-$5.50 | 1.68 million | 5/9/2017 | National Securities, Dougherty & Company |
| Ensemble Health Partners, Inc. | ENSB | Postponed | Postponed | 10/28/2021 | Goldman Sachs, BofA Securities, Deutsche Bank, Guggenheim Securities, Credit Suisse, Evercore ISI, Wells Fargo Securities, SVB Leerink |
| Entasis Therapeutics Holdings Inc. | ETTX | $16.00-$18.00 | 5 million | 9/26/2018 | Credit Suisse, BMO Capital Markets |
| Entellus Medical | ENTL | $15.00-$17.00 | 4.6 million | 1/29/2015 | BofA Merrill Lynch, Piper Jaffray
|
| Entera Bio Ltd. | ENTX | $8.00-$10.00 | 1.3 million | 6/28/2018 | Maxim Group |
| Entrada Therapeutics, Inc. | TRDA | $19.00-$21.00 | 9.075 million | 10/29/2021 | Goldman Sachs, Cowen, Evercore ISI |
| Envision Healthcare Holdings | EVHC | $20.00-$23.00 | 42 million | 8/14/2013 | Barclays, BofA Merrill Lynch, Citigroup |
| Envista Holdings Corporation | NVST | $21.00-$24.00 | 26.8 million | 9/18/2019 | JP Morgan, Goldman Sachs, Morgan Stanley |
| Enzymotec Ltd. | ENZY | $16.00-$18.00 | 4.4 million | 9/27/2013 | BofA Merrill Lynch, Jefferies, Wells Fargo Securities |
| Epocrates, Inc. | EPOC | | | 0/0/0 | J.P. Morgan |
| Equillium, Inc. | EQ | $14.00-$16.00 | 4.7 million | 10/12/2018 | Jefferies, Leerink, Stifel |
| Erasca, Inc. | ERAS | $14.00-$16.00 | 18.75 million | 7/16/2021 | J.P. Morgan, Morgan Stanley, BofA Securities, Evercore ISI, Guggenheim Securities
|
| ERYTECH Pharma S.A. | ERYP | $23.00-$24.00 | 4.7 million ADSs | 11/10/2017 | Jefferies, Cowen, Oddo BHF |
| Esperion Therapeutics, Inc. | ESPR | $13.00-$15.00 | 5 million | 6/26/2013 | Credit Suisse, Citigroup |
| Establishment Labs Holdings Inc. | ESTA | $15.00-$17.00 | 3.7 million | 7/19/2018 | Jefferies, Cowen, BTIG |
| Eton Pharmaceuticals, Inc. | ETON | $6.00-$6.00 | 3.6 million | 11/14/2018 | National Securities |
| Evaxion Biotech A/S | EVAX | $10.00-$12.00 | 3 million | 2/5/2021 | Oppenheimer |
| Evelo Biosciences, Inc. | EVLO | $15.00-$17.00 | 5.3 million | 5/9/2018 | Morgan Stanley, Cowen, BMO Capital Markets |
| Everside Health Group, Inc. | EVSD | Withdrawn | Withdrawn | 0/0/0 | Morgan Stanley, JP Morgan, Goldman Sachs, BofA Securities, William Blair |
| Evoke Pharma | EVOK | $12.00-$14.00 | 2.1 million | 9/25/2013 | Aegis Capital Corp |
| Evolent Health | EVH | $14.00-$16.00 | 11.5 million | 6/5/2015 | J.P. Morgan, Goldman Sachs & Co. |
| Evolus, Inc. | EOLS | $12.00-$14.00 | 5 million | 2/8/2018 | Cantor, Mizuho Securities |
| Evommune, Inc. | EVMN | $15.00-$17.00 | 9.375 million | 11/6/2025 | Morgan Stanley, Leerink Partners, Evercore ISI, Cantor
|
| Evotec SE | EVO | $26.16-$26.16 | 20 million ADSs | 11/4/2021 | BofA Securities, Morgan Stanley, Citigroup, Jefferies, Cowen, RBC Capital Markets |
| Exagen Diagnostics, Inc. | EXDX | TBD | TBD | 0/0/0 | Leerink Partners, Baird |
| Exagen Inc. | XGN | $14.00-$16.00 | 3.6 million | 9/19/2019 | Cowen, Cantor, William Blair |
| Exscientia Limited | EXAI | $20.00-$22.00 | 13.85 million | 10/1/2021 | Goldman Sachs, Morgan Stanley, BofA Securities, Barclays |
| Eyenovia, Inc. | EYEN | $10.00-$12.00 | 2.73 million | 1/25/2018 | Ladenburg Thalmann, Roth Capital Partners |
| Fate Therapeutics, Inc. | FATE | $6.00-$8.00 | 6.7 million | 10/1/2013 | Cowen & Co., BMO Capital Markets |
| FibroGen, Inc. | FGEN | $16.00-$19.00 | 8.1 million | 11/14/2014 | Goldman Sachs & Co., Citigroup, Leerink Partners
|
| Finch Therapeutics Group, Inc. | FNCH | $15.00-$17.00 | 7.5 million | 3/19/2021 | BofA Securities, Jefferies, Evercore ISI |
| Fireman B.V. | IFRX | $14.00-$16.00 | 6.67 million | 11/8/2017 | J.P. Morgan, Leerink Partners, BMO Capital Markets |
| Five Prime Therapeutics | FPRX | $12.00-$14.00 | 2.8 million | 9/18/2013 | Jefferies, BMO Capital Markets, Wells Fargo Securities |
| Flex Pharma | FLKS | $12.00-$14.00 | 5.4 million | 1/29/2015 | Jefferies, Piper Jaffray |
| Flexion Therapeutics, Inc. | FLXN | $12.00-$14.00 | 5 million | 2/12/2014 | BMO Capital Markets, Wells Fargo Securities |
| Foamix Pharmaceuticals | FOMX | $10.00-$12.00 | 6.7 million | 9/18/2014 | Barclays, Cowen and Company
|
| Foghorn Therapeutics Inc. | FHTX | $15.00-$17.00 | 7.5 million | 10/23/2020 | Goldman Sachs, Morgan Stanley, Cowen |
| Forma Therapeutics Holdings, Inc. | FMTX | $16.00-$18.00 | 13.8 million | 6/19/2020 | Jefferies, SVB Leerink, Credit Suisse |
| Forty Seven, Inc. | FTSV | $14.00-$16.00 | 7 million | 6/28/2018 | Morgan Stanley, Credit Suisse |
| Forward Pharma | FWP | $20.00-$22.00 | 10.5 million | 10/15/2014 | Leerink Partners, Jefferies, RBC Capital Markets
|
| Foundation Medicine | FMI | $14.00-$16.00 | 5.89 million | 9/25/2013 | Goldman Sachs, J.P. Morgan |
| Fractyl Health, Inc. | GUTS | $14.00-$16.00 | 7.33 million | 2/2/2024 | BofA Securities, Morgan Stanley, Evercore ISI |
| Freeline Therapeutics Holdings plc | FRLN | $16.00-$18.00 | 8.8 million ADSs | 8/7/2020 | JP Morgan, Morgan Stanley, Evercore |
| Frequency Therapeutics, Inc. | FREQ | $14.00-$16.00 | 6.0 million | 10/3/2019 | J.P. Morgan, Goldman Sachs, Cowen |
| Fulcrum Therapeutics, Inc. | FULC | $16.00-$18.00 | 4.5 million | 7/18/2019 | Morgan Stanley, BofA Merrill Lynch, SVB Leerink |
| Fulgent Genetics, Inc. | FLGT | $12.00-$14.00 | 4.2 million | 9/29/2016 | Credit Suisse, Piper Jaffray, Raymond James |
| Fusion Pharmaceuticals Inc. | FUSN | $14.00-$16.00 | 12.5 million | 6/26/2020 | Morgan Stanley, Jefferies, Cowen |
| G1 Therapeutics, Inc. | GTHX | $15.00-$17.00 | 7 million | 5/17/2017 | J.P. Morgan, Cowen and Company |
| Gain Therapeutics, Inc. | GANX | $10.00-$12.00 | 3.6 million | 3/18/2021 | BTIG, Oppenheimer |
| Galecto, Inc. | GLTO | $14.00-$16.00 | 5.7 million | 10/29/2020 | BofA Securities, SVB Leerink, Credit Suisse |
| Galera Therapeutics, Inc. | GRTX | $14.00-$16.00 | 5 million | 11/7/2019 | BofA Merrill Lynch, Citigroup, Credit Suisse |
| Gamida Cell Ltd. | GMDA | $13.00-$15.00 | 6.25 million | 10/26/2018 | BMO Capital, RBC Capital |
| Gemphire Therapeutics | GEMP | $11.00-$13.00 | 3 million | 8/5/2016 | Jefferies, RBC Capital Markets |
| Generate Biomedicines, Inc. | GENB | $15.00-$17.00 | 25 million | 2/27/2026 | Goldman Sachs, Morgan Stanley, Piper Sandler, Guggenheim Securities,
Cantor
|
| Generation Bio Co. | GBIO | $16.00-$18.00 | 10.5 million | 6/12/2020 | JP Morgan, Jefferies, Cowen |
| Genetron Holdings Limited | GTH | $11.50-$13.50 | 16 million ADSs | 6/19/2020 | Credit Suisse, CICC |
| Genfit S.A. | GNFT | $26.33-$26.33 | 6.7 million ADSs | 3/27/2019 | SVB Leerink, Barclays |
| Genmab A/S | GMAB | $18.11-$18.11 | 28.5 million ADSs | 7/18/2019 | BofA Merrill Lynch, Morgan Stanley, Jefferies, Guggenheim Securities, RBC Capital |
| Genprex, Inc. | GNPX | $5.00-$5.00 | 1.3 million | 3/29/2018 | Network 1 Financial |
| GenSight Biologics S.A. | GNST | Withdrawn | | 11/6/2015 | Leerink Partners, Evercore ISI, Canaccord Genuity |
| GH Research PLC | GHRS | $14.00-$16.00 | 10 million | 6/25/2021 | Cowen, Stifel |
| Glaukos Corporation | GKOS | $13.00-$15.00 | 6 million | 6/25/2015 | J.P. Morgan, BofA Merrill Lynch, Goldman Sachs & Co. |
| Global Blood Therapeutics | GBT | $16.00-$18.00 | 6 million | 8/12/2015 | Morgan Stanley, Goldman Sachs & Co. |
| Globus Medical | GMED | $16.00-$18.00 | 8.33 million | 8/3/2012 | BofA Merrill Lynch, Goldman Sachs, Piper Jaffray |
| GlycoMimetics | GLYC | $14.00-$16.00 | 7.0 million | 1/10/2014 | Jefferies, Barclays |
| GMR Solutions Inc. | GMRS | $15.00-$15.00 | 31.9 million | 5/13/2026 | J.P. Morgan, KKR, BofA Securities, Barclays, Goldman Sachs, Citigroup, Evercore ISI, Morgan Stanley, UBS Investment Bank |
| GoHealth, Inc. | GOCO | $18.00-$20.00 | 43.5 million | 7/15/2020 | Goldman Sachs, BofA Securities, Morgan Stanley, Barclays, Credit Suisse, Evercore ISI, RBC Capital Markets, William Blair |
| GoodRx Holdings, Inc. | GDRX | $24.00-$28.00 | 34.6 million | 9/23/2020 | Morgan Stanley, Goldman Sachs, J.P. Morgan, Barclays, BofA Securities, Citigroup, Credit Suisse, RBC Capital Markets, UBS Investment Bank, Cowen, Deutsche Bank Securities, Evercore ISI
|
| Gossamer Bio, Inc. | GOSS | $16.00-$16.00 | 17.25 million | 2/8/2019 | BofA Merrill Lynch, Leerink, Barclays, Evercore ISI |
| Gracell Biotechnologies Inc. | GRCL | $16.00-$18.00 | 11 million | 1/8/2021 | Citigroup, Jefferies, Piper Sandler, Wells Fargo |
| GRAIL, Inc. | GRAL | Withdrawn | Withdrawn | 0/0/0 | Morgan Stanley, Goldman Sachs, BofA Securities, Cowen, Evercore ISI
|
| Graphite Bio, Inc. | GRPH | $15.00-$17.00 | 14 million | 6/25/2021 | Morgan Stanley, BofA Securities, Cowen, SVB Leerink |
| Graybug Vision, Inc. | GRAY | $15.00-$17.00 | 5.625 million | 9/25/2020 | SVB Leerink, Piper Sandler |
| Greenlane Holdings, Inc. | GNLN | $14.00-$16.00 | 6 million | 4/18/2019 | Cowen, Canaccord Genuity |
| Gritstone Oncology, Inc. | GRTS | $13.00-$15.00 | 6.7 million | 9/28/2018 | Goldman Sachs, Cowen, Barclays |
| Guardant Health, Inc. | GH | $15.00-$17.00 | 12.5 million | 10/4/2018 | JP Morgan, BofA Merrill Lynch |
| Guardian Pharmacy Services, Inc. | GRDN | 8 million | $14.00-$16.00 | 9/26/2024 | Raymond James, Stephens Inc., Truist Securities |
| Gyroscope Therapeutics Holdings plc | VISN | Postponed | Postponed | 5/7/2021 | Morgan Stanley, Goldman Sachs, Citigroup
|
| Hancock Jaffe Laboratories, Inc. | HJLI | $6.00-$8.00 | 1.5 million | 5/31/2018 | Network 1 Financial |
| Harmony Biosciences Holdings, Inc. | HRMY | $20.00-$23.00 | 5.3 million | 8/19/2020 | Goldman Sachs, Jefferies, Piper Sandler
|
| Harpoon Therapeutics, Inc. | HARP | $13.00-$15.00 | 5.4 million | 2/8/2019 | Citigroup, SVB Leerink |
| Health Catalyst, Inc. | HCAT | $20.00-$23.00 | 7 million | 7/25/2019 | Goldman Sachs & Co., J.P. Morgan, William Blair |
| Healthcare Royalty, Inc | HCRX | Postponed | Postponed | 8/6/2021 | Goldman Sachs, Citigroup, Credit Suisse, Jefferies, Cowen, SVB Leerink |
| hear.com N.V. | HCG | Postponed | Postponed | 5/14/2021 | Morgan Stanley, JP Morgan, Deutsche Bank, Goldman Sachs |
| Heartflow, Inc. | HTFL | $17.00-$18.00 | 16.7 million | 8/8/2025 | J.P. Morgan, Morgan Stanley, Piper Sandler, Stifel, Canaccord Genuity |
| Heat Biologics | HTBX | $10.00-$12.00 | 2.5 million | 7/24/2013 | Aegis Capital Corp |
| Hemab Therapeutics, Inc. | COAG | $16.00-$18.00 | 16.75 million | 5/1/2026 | Goldman Sachs, Jefferies, Evercore ISI |
| HilleVax, Inc. | HLVX | $16.00-$18.00 | 11.8 million | 4/29/2022 | J.P. Morgan, SVB Leerink, Stifel, Guggenheim Securites |
| Hinge Health, Inc. | HNGE | $28.00-$32.00 | 13.7 million | 5/22/2025 | Morgan Stanley, Barclays, BofA Securities, Evercore ISI, RBC Capital, Truist Securities, Stifel, William Blair, Piper Sandler, Canaccord Genuity, KeyBanc Capital, Needham & Co., Raymond James, KKR |
| Histogenics Corporation | HSGX | $13.00-$15.00 | 5.91 million | 12/3/2014 | Cowen & Co., Needham & Co., Canaccord Genuity |
| Homology Medicines, Inc. | FIXX | $14.00-$16.00 | 9 million | 3/28/2018 | BofA Merrill Lynch, Cowen, Evercore ISI |
| HOOKIPA Pharma Inc. | HOOK | $14.00-$16.00 | 6 million | 4/18/2019 | BofA Merrill Lynch, SVB Leerink , RBC Capital |
| HTG Molecular Diagnostics | HTGM | $13.00-$15.00 | 3.6 million | 5/6/2015 | Leerink Partners |
| Hyperion Therapeutics, Inc | HPTX | $11.00-$13.00 | 5 million | 7/26/2012 | Leerink, Cowen & Company |
| I-Mab | IMAB | $12.00-$15.00 | 7.4 million ADSs | 1/17/2020 | Jefferies, CICC |
| Iambic Therapeutics, Inc. | IAM | $15.00-$17.00 | 9.375 million | 10/15/2026 | J.P. Morgan, Jefferies, BofA Securities, Citigroup |
| IASIS Healthcare Corporation | IAS | TBD | TBD | 0/0/0 | BofA Merrill Lynch, Barclays, J.P. Morgan |
| Icosavax, Inc. | ICVX | $14.00-$16.00 | 12.1 million | 7/29/2021 | Jefferies, Cowen, Evercore ISI, William Blair |
| IDEAYA Biosciences, Inc. | IDYA | $13.00-$15.00 | 5 million | 5/23/2019 | JP Morgan, Citigroup, Jefferies |
| IGM Biosciences, Inc. | IGMS | $15.00-$17.00 | 10.9 million | 9/18/2019 | Jefferies, Piper Jaffray, Stifel, Guggenheim Securities |
| iKang Healthcare Group, Inc. | KANG | $12.00-$14.00 | 10.9 million | 4/9/2014 | BofA Merrill Lynch, UBS Investment Bank |
| Ikena Oncology, Inc. | IKNA | $15.00-$17.00 | 7.8 million | 3/26/2021 | Jefferies, Cowen, Credit Suisse, William Blair |
| Imago BioSciences, Inc. | IMGO | $14.00-$16.00 | 8.4 million | 7/16/2021 | Jefferies, Cowen, Stifel, Guggenheim Securities |
| Imara Inc | IMRA | $16.00-$18.00 | 4.7 million | 3/12/2020 | Morgan Stanley, Citigroup, SVB Leerink |
| Immune Design Corp | IMDZ | $12.00-$14.00 | 5 million | 7/24/2014 | Jefferies, Leerink Partners, Wells Fargo Securities |
| Immuneering Corporation | IMRX | $14.00-$16.00 | 7.5 million | 7/30/2021 | Morgan Stanley, Jefferies, Cowen, Guggenheim Securities
|
| Immunocore Holdings plc | IMCR | $23.00-$25.00 | 9.9 million ADSs | 2/5/2021 | Goldman Sachs, JP Morgan, Jefferies
|
| Immunome Inc. | IMNM | $11.00-$13.00 | 3.25 million | 10/2/2020 | Ladenburg Thalmann, Chardan |
| Impel NeuroPharma, Inc. | IMPL | $14.00-$16.00 | 5.33 million | 4/23/2021 | Cowen, Guggenheim |
| IN8bio, Inc. | INAB | $10.00-$12.00 | 4 million | 7/30/2021 | B. Riley Securities |
| Inari Medical, Inc. | NARI | $14.00-$16.00 | 8.2 million | 5/22/2020 | BofA Securities, Morgan Stanley |
| INC Research Holdings, Inc. | INCR | $17.00-$20.00 | 8.1 million | 11/7/2014 | Goldman Sachs, Credit Suisse |
| Inhibrx, Inc. | INBX | $16.00-$18.00 | 7 million | 8/19/2020 | Jefferies, Evercore ISI, Credit Suisse |
| InMode Ltd. | INMD | $14.00-$16.00 | 5 million | 8/8/2019 | Barclays, UBS Investment Bank, Canaccord Genuity |
| Innate Pharma S.A | IPHA | $7.50-$7.50 | 12.5 million ADSs | 10/17/2019 | Citigroup, SVB Leerink, Evercore ISI |
| Innocoll GmbH | INNL | $13.00-$15.00 | 6.3 million | 7/25/2014 | Piper Jaffray, Stifel |
| InnovAge Holding Corp | INNV | $20.00-$21.00 | 16.7 million | 3/4/2021 | JP Morgan, Barclays, Goldman Sachs, Citigroup |
| Inogen, Inc. | INGN | $16.00-$18.00 | 4.4 million | 2/14/2014 | J.P. Morgan |
| Inotek Pharmaceuticals Corporation | ITEK | $13.00-$15.00 | 6.67 million | 2/18/2015 | Cowen & Co., Piper Jaffray
|
| Inozyme Pharma, Inc. | INZY | $16.00-$16.00 | 7 million | 7/24/2020 | BofA Securities, Cowen, Piper Sandler |
| Inspire Medical Systems, Inc. | INSP | $14.00-$16.00 | 6.75 million | 5/3/2018 | BofA Merrill Lynch, Goldman Sachs & Co. |
| Instil Bio, Inc. | TIL | $19.00-$20.00 | 16 million | 3/19/2021 | Morgan Stanley, Jefferies, Cowen |
| Insys Therapeutics, Inc. | INSY | $16.00-$18.00 | 4 million | 5/2/2013 | Wells Fargo Securities, JMP Securities |
| Intellia Therapeutics | NTLA | Priced at $18.00 | 6 million | 5/6/2016 | Credit Suisse, Jefferies, Leerink Partners |
| Intercept Pharmaceuticals | ICPT | $13.00-$15.00 | 5 million | 10/11/2012 | BofA Merrill Lynch, Citigroup, Goldman Sachs |
| Intersect ENT, Inc. | XENT | $11.00-$13.00 | 5 milion | 7/24/2014 | J.P. Morgan, Piper Jaffray |
| Intrexon | XON | $14.00-$16.00 | 10 million | 8/8/2013 | J.P. Morgan, Barclays Capital |
| Intuity Medical, Inc. | POGO | TBD | TBD | 0/0/0 | Goldman Sachs, Jefferies, Piper Sandler |
| Invea Therapeutics, Inc. | INAI | Withdrawn | Withdrawn | 0/0/0 | BofA Securities, Citigroup, Truist Securities |
| inVentiv Group Holdings | INV | Withdrawn | Withdrawn | 0/0/0 | Credit Suisse, Morgan Stanley, Goldman Sachs & Co., Jefferies |
| Inventiva S.A | IVA | $13.40-$15.40 | 7.48 million ADSs | 7/10/2020 | Jefferies, Stifel, Guggenheim Securities |
| Invitae Corporation | NVTA | $13.00-$15.00 | 6.35 million | 2/12/2015 | J.P. Morgan |
| Invuity, Inc. | IVTY | $14.00-$16.00 | 4 million | 6/15/2015 | Piper Jaffray, Leerink Partners, Stifel |
| IO Biotech, Inc. | IOBT | $14.00-$17.00 | 7.15 million | 11/5/2021 | Morgan Stanley, Jefferies, Cowen |
| iRadimed Inc. | IRMD | $5.00-$6.00 | 2.02 million | 7/16/2014 | Roth Capital Partners |
| IsoPlexis Corporation | ISO | $14.00-$16.00 | 8.33 million | 10/8/2021 | Morgan Stanley, Cowen, Evercore, SVB Leerink
|
| iTeos Therapeutics, Inc. | ITOS | $16.00-$18.00 | 10.6 million | 7/24/2020 | JP Morgan, SVB Leerink, Piper Sandler |
| Iterum Therapeutics plc | ITRM | $14.00-$16.00 | 6.2 million | 5/25/2018 | Leerink Partners, RBC Capital Partners |
| Jaguar Animal Health | JAGX | $7.00-$9.00 | 2.86 million | 5/13/2015 | Aegis Capital Corp |
| Janux Therapeutics, Inc. | JANX | $15.00-$17.00 | 11.4 million | 6/11/2021 | BofA Securities, Cowen, Evercore ISI |
| Jounce Therapeutics | JNCE | $13.00-$15.00 | 6.365 million | 1/27/2017 | J.P. Morgan, Cowen and Company |
| Journey Medical Corporation | DERM | $10.00-$12.00 | 3.5 million | 11/12/2021 | B. Riley Securities |
| Juno Therapeutics | JUNO | $15.00-$18.00 | 11.02 million | 12/19/2014 | Morgan Stanley, J.P. Morgan, Goldman Sachs & Co. |
| K2M Group Holdings, Inc. | KTWO | $16.00-$18.00 | 8.83 million | 5/8/2014 | Piper Jaffray, Barclays, Wells Fargo Securities
|
| Kadmon Holdings, LLC | KDMN | $16.00-$20.00 | 6.25 million | 7/27/2016 | Citigroup, Jefferies |
| Kailera Therapeutics, Inc. | KLRA | $14.00-$16.00 | 39.1 million | 4/17/2026 | J.P. Morgan, Leerink Partners, TD Cowen, Evercore ISI |
| Kala Pharmaceuticals, Inc. | KALA | $14.00-$16.00 | 6 million | 7/20/2017 | J.P. Morgan, BofA Merrill Lynch, Wells Fargo Securities |
| Kaleido Biosciences, Inc. | KLDO | $20.00-$22.00 | 5 million | 2/28/2019 | Goldman Sachs, J.P. Morgan, Morgan Stanley |
| KaloBios Pharmaceuticals | KBIO | $12.00-$14.00 | 8.75 million | 1/31/2013 | Leerink Swann |
| Kardigan Inc. | KARD | $14.00-$16.00 | 23.3 million | 6/18/2026 | J.P. Morgan, Jefferies, Leerink Partners, TD Cowen |
| Karuna Therapeutics, Inc | KRTX | $15.00-$17.00 | 5.6 million | 6/28/2019 | Goldman Sachs, Citigroup, Wells Fargo |
| Karyopharm Therapeutics | KPTI | $14.00-$16.00 | 5.7 million | 11/6/2013 | BofA Merrill Lynch, J.P. Morgan, Leerink Partners |
| KCI Holdings, Inc. | TBD | Withdrawn | Withdrawn | 0/0/0 | JP Morgan, Goldman Sachs, BofA Merrill Lynch |
| KemPharm, Inc. | KMPH | $12.00-$14.00 | 5.09 million | 4/16/2015 | Cowen & Co., RBC Capital Markets |
| Kenvue Inc. | KVUE | $20.00-$23.00 | 172.8 million | 5/4/2023 | Goldman Sachs, JP Morgan, BofA Securities, Citigroup, Deutsche Bank, BNP PARIBAS, HSBC, RBC Capital Markets, UBS Investment Bank |
| Keros Therapeutics, Inc. | KROS | $14.00-$16.00 | 6 million | 4/8/2020 | Jefferies, SVB Leerink, Piper Sandler |
| Kestra Medical Technologies, Ltd. | KMTS | $14.00-$16.00 | 11.9 million | 3/6/2025 | BofA Securities, Goldman Sachs, Piper Sandler, Wells Fargo, Stifel |
| Kezar Life Sciences, Inc. | KZR | $14.00-$16.00 | 5 million | 6/21/2018 | Jefferies, Cowen, Wells Fargo, William Blair |
| Kindred Biosciences, Inc. | KIN | $6.00-$8.00 | 7.5 million | 12/12/2014 | Leerink Partners, BMO Capital Markets, Guggenheim Securities |
| Kiniksa Pharmaceuticals, Ltd. | KNSA | $17.00-$19.00 | 8.5 million | 5/24/2018 | Goldman Sachs, J.P. Morgan |
| Kinnate Biopharma Inc. | KNTE | $18.00-$19.00 | 12 million | 12/3/2020 | Goldman Sachs, SVB Leerink , Piper Sandler |
| Kite Pharma, Inc., | KITE | $15.00-$16.00 | 7.5 million | 6/20/2014 | Jefferies, Credit Suisse, Cowen and Co. |
| Kodiak Sciences Inc. | KOD | $13.00-$15.00 | 9 million | 10/4/2018 | Morgan Stanley, BofA Merrill Lynch |
| Kronos Bio, Inc. | KRON | $16.00-$18.00 | 13.2 million | 10/9/2020 | Goldman Sachs, Jefferies, Cowen, Piper Sandler |
| Krystal Biotech, Inc. | KRYS | $9.00-$11.00 | 3.96 million | 9/20/2017 | Ladenburg Thalmann |
| Kymera Therapeutics, Inc. | KYMR | $16.00-$18.00 | 8.7 million | 8/21/2020 | Morgan Stanley, BofA Securities, Cowen, Guggenheim Securities |
| Kythera Biopharmaceuticals, Inc. | KYTH | $14.00-$16.00 | 5.1 million | 10/11/2012 | J.P. Morgan, Goldman Sachs & Co.
|
| Kyverna Therapeutics Inc. | KYTX | $20.00-$21.00 | 14.5 million | 2/8/2024 | JP Morgan, Morgan Stanley, Leerink Partners, Wells Fargo |
| Landos Biopharma, Inc. | LABP | $15.00-$17.00 | 6.25 million | 2/4/2021 | JP Morgan, Jefferies, SVB Leerink |
| Lantheus Holdings | LNTH | $8.50-$10.50 | 10.83 million | 6/25/2015 | Credit Suisse, Jefferies, RBC Capital Markets, Wells Fargo Securities |
| Latigo Biotherapeutics, Inc. | LTGO | $16.00-$18.00 | 19.2 million | 8/7/2026 | Goldman Sachs, Jefferies, Leerink Partners, Guggenheim Securities |
| Lava Therapeutics B.V. | LVTX | $14.00-$16.00 | 6.7 million | 3/25/2021 | JP Morgan, Jefferies, SVB Leerink |
| LB Pharmaceuticals Inc. | LBRX | $14.00-$16.00 | 19 million | 9/11/2025 | Leerink, Piper Sandler, Stifel |
| LDR Holding | LDRH | $14.00-$16.00 | 5 million | 10/9/2013 | Piper Jaffray, William Blair |
| Legend Biotech Corporation | LEGN | $18.00-$20.00 | 18.4 million | 6/5/2020 | Morgan Stanley, JP Morgan, Jefferies |
| Lexeo Therapeutics, Inc. | LXEO | $13.00-$15.00 | 9.1 million | 11/3/2023 | J.P. Morgan, Leerink Partners, Stifel, RBC Capital Markets |
| LianBio | LIAN | $15.00-$17.00 | 20.3 million ADSs | 11/1/2021 | Goldman Sachs, Jefferies, BofA Securities |
| LifeStance Health Group, Inc. | LFST | $15.00-$17.00 | 40 million | 6/10/2021 | Morgan Stanley, Goldman Sachs, JP Morgan, Jefferies, TPG Capital BD, UBS Investment Bank, William Blair
|
| LinkDoc Technology Limited | LDOC | Postponed | Postponed | 7/9/2021 | Morgan Stanley, BofA Securities, CICC |
| Liposcience, Inc. | LPDX | $13.00-$15.00 | 5 million | 1/25/2013 | Barclays Capital, UBS Investment Bank, Piper Jaffray |
| Liquidia Technologies, Inc. | LQDA | $10.00-$12.00 | 4.54 million | 7/26/2018 | Jefferies, Cowen |
| LogicBio Therapeutics, Inc. | LOGC | $12.00-$14.00 | 7 million | 10/19/2018 | Jefferies, Barclays, William Blair, Chardan |
| Longboard Pharmaceuticals, Inc. | LBPH | $14.00-$16.00 | 5 million | 3/12/2021 | Citigroup, Evercore ISI, Guggenheim Securities, Cantor |
| Loxo Oncology, Inc. | LOXO | $12.00-$14.00 | 5.3 million | 8/1/2014 | Cowen & Co., Stifel |
| Lucid Diagnostics, Inc. | LUCD | $14.00-$16.00 | 5 million | 10/14/2021 | Cantor, Canaccord Genuity |
| Lucira Health, Inc. | LHDX | $15.00-$17.00 | 9 million | 2/5/2021 | BofA Securities, William Blair |
| Lumenis Ltd. | LMNS | $15.00-$17.00 | 6.25 million | 2/27/2014 | Goldman Sachs, Credit Suisse, Jefferies |
| Lumexa Imaging Holdings, Inc. | LMRI | $17.00-$20.00 | 25 million | 12/11/2025 | Barclays, J.P. Morgan, Jefferies, Deutsche Bank, Wells Fargo, Leerink Partners, William Blair, Capital One Securities, Fifth Third Securities, Raymond James, PNC Capital Markets, Academy Securities, Loop Capital Markets, R. Seelaus & Co. |
| LumiraDx Limited | LMDX | Withdrawn | Withdrawn | 0/0/0 | Jefferies, SVB Leerink, Evercore ISI, Raymond James
|
| Lycia Therapeutics Inc. | LYCA | $16.00-$18.00 | 17.6 million | 10/23/2026 | Jefferies, TD Cowen, Evercore ISI, Guggenheim Securities, LifeSci Capital |
| Lyell Immunopharma, Inc. | LYEL | $16.00-$18.00 | 25 million | 6/17/2021 | Goldman Sachs, BofA Securities, JP Morgan, Morgan Stanley |
| Lyra Therapeutics, Inc. | LYRA | $14.00-$16.00 | 3.5 million | 5/1/2020 | BofA Securities, Jefferies, William Blair |
| Macrocure Ltd. | MCUR | $13.00-$15.00 | 5.4 million | 7/31/2014 | Credit Suisse, Jefferies |
| MacroGenics, Inc. | MGNX | $14.00-$16.00 | 5 million | 10/10/2013 | BofA Merrill Lynch, Leerink Swann |
| Magenta Therapeutics, Inc. | MGTA | $14.00-$16.00 | 6.7 million | 6/21/2018 | J.P. Morgan, Goldman Sachs, Cowen |
| Mainz Biomed B.V. | MYNZ | $4.00-$6.00 | 2 million | 11/4/2021 | Boustead Securities, LLC |
| Maplight Therapeutics Inc. | MPLT | $17.00-$17.00 | 14.75 million | 10/27/2025 | Morgan Stanley, Jefferies, Leerink Partners, Stifel |
| Maravai LifeSciences Holdings, Inc. | MRVI | $24.00-$27.00 | 60 million | 11/20/2020 | Morgan Stanley, Jefferies, Goldman Sachs, BofA Securities, Credit Suisse, UBS Investment Bank, Baird, William Blair, Stifel, KeyBanc Capital |
| Marinus Pharmaceuticals | MRNS | $12.00-$14.00 | 5.62 million | 7/31/2014 | Stifel, JMP Securities |
| MaxCyte Inc. | MXCT | $11.50-$13.50 | 13.5 million | 7/30/2021 | Cowen, Stifel, William Blair |
| Maze Therapeutics Inc. | MAZE | $15.00-$17.00 | 8.75 million | 1/31/2025 | J.P. Morgan, TD Cowen, Leerink Partners, Guggenheim Securities |
| MBX Biosciences, Inc. | MBX | $14.00-$16.00 | 10.2 million | 9/13/2024 | J.P. Morgan, Jefferies, Stifel, Guggenheim Securities |
| MDxHealth, Inc. | MDXH | $13.46-$13.46 | 3.75 million ADSs | 11/4/2021 | Piper Sandler, Oppenheimer & Co. |
| Mediwound Ltd. | MDWD | $14.00-$16.00 | 5 million | 3/20/2014 | Credit Suisse, Jefferies, BMO Capital Markets |
| Medline Inc. | MDLN | 216 million | $26.00-$30.00 | 12/17/2025 | Goldman Sachs & Co. LLC; Morgan Stanley; BofA Securities; J.P. Morgan, Barclays, Citigroup, Deutsche Bank Securities, Jefferies, UBS, Evercore ISI, BMO Capital, BNP PARIBAS, MUFG, RBC Capital, Santander, SOCIETE GENERALE, TD Cowen,Wells Fargo, Wolfe Nomura Alliance, Leerink Partners, Macquarie Capital, Mizuho, Piper Sandler, Truist Securities, William Blair |
| MedPace Holdings | MEDP | $20.00-$23.00 | 7 million | 8/11/2016 | Jefferies, Credit Suisse, UBS Investment Bank, Wells Fargo Securities |
| MeiraGTx Holdings plc | MGTX | $14.00-$16.00 | 5 million | 6/8/2018 | BofA Merrill Lynch, Barclays, Evercore ISI |
| Menlo Therapeutics, Inc. | MNLO | $14.00-$16.00 | 7 million | 1/25/2018 | Jefferies, Piper Jaffray, Guggenheim Securities |
| Mereo Biopharma Group plc | MREO | Postponed | Postponed | 0/0/0 | Cowen, BMO, RBC Capital |
| Merrimack Pharmaceuticals | MACK | $8.00-$10.00 | 14.3 million | 3/29/2012 | J.P. Morgan, BofA Merrill Lynch |
| Mersana Therapeutics, Inc. | MRSN | $14.00-$16.00 | 5 million | 6/28/2017 | J.P. Morgan, Cowen and Company, Leerink Partners |
| Merus B.V. | MRUS | $14.00-$16.00 | 5.5 million | 5/19/2016 | Citigroup, Jefferies |
| Metacrine, Inc. | MTCR | $12.00-$14.00 | 6.5 million | 9/16/2020 | Jefferies, Evercore ISI, RBC Capital Markets |
| Metagenomi, Inc. | MGX | $15.00-$17.00 | 6.25 million | 2/9/2024 | J.P. Morgan, Jefferies, TD Cowen, Wells Fargo Securities, BMO Capital Markets |
| Metsera, Inc. | MTSR | $15.00-$17.00 | 15.3 million | 1/31/2025 | BofA Securities, Goldman Sachs, Evercore ISI, Guggenheim Securities, Cantor
|
| Milestone Pharmaceuticals Inc. | MIST | $14.00-$16.00 | 5.5 million | 5/9/2019 | Jefferies, Cowen, Piper Jaffray, Oppenheimer & Co. |
| Mineralys Therapeutics, Inc. | MLYS | $14.00-$16.00 | 12 million | 2/10/2023 | BofA Securities, Evercore ISI, Stifel, Guggenheim Securities, Credit Suisse, Wells Fargo |
| Minerva Neurosciences | NERV | $10.00-$12.00 | 5.5 million | 7/1/2014 | Jefferies |
| Minerva Surgical, Inc | UTRS | $15.00-$17.00 | 6.25 million | 10/22/2021 | J.P. Morgan, Piper Sandler, UBS Investment Bank, SVB Leerink |
| MiniMed Group, Inc. | MMED | $25.00-$28.00 | 28 million | 3/6/2026 | Goldman Sachs, BofA Securities, Citigroup, Morgan Stanley, Barclays, Deutsche Bank, Mizuho, Wells Fargo |
| MiNK Therapeutics, Inc. | INKT | $12.00-$14.00 | 3.33 million | 10/15/2021 | Evercore ISI, William Blair |
| Mirna Therapeutics | MIRN | $13.00-$15.00 | 6.25 million | 10/1/2015 | Citigroup, Leerink Partners |
| Miromatrix Medical, Inc | MIRO | $7.00-$9.00 | 4.8 million | 6/24/2021 | Craig Hallum |
| Mirum Pharmaceuticals, Inc. | MIRM | $14.00-$16.00 | 5 million | 7/18/2019 | Citigroup, Evercore ISI, Guggenheim Securities |
| Mobia Medical, Inc. | MOBI | $14.00-$16.00 | 10 million | 5/8/2026 | BofA Securities, J.P. Morgan, Goldman Sachs, BTIG, Wolfe Nomura Alliance |
| Moderna, Inc. | MRNA | $22.00-$24.00 | 26 million | 12/7/2018 | Morgan Stanley, Goldman Sachs & Co., J.P. Morgan, BofA Merrill Lynch, Barclays, Piper Jaffray |
| Molecular Partners Inc. | MOLN | $27.14-$27.14 | 3 million ADSs | 6/16/2021 | JP Morgan, SVB Leerink, Cowen, RBC Capital
|
| Moleculin Biotech, Inc. | MBRX | $5.00-$6.00 | 1.54 million | 6/2/2016 | Bonwick Capital Partners LLC, Network 1 Financial Securities |
| Monte Rosa Therapeutics Inc. | GLUE | $17.00-$19.00 | 11.7 million | 6/24/2021 | JP Morgan, Cowen, Piper Sandler, Guggenheim |
| Morphic Holding, Inc. | MORF | $14.00-$16.00 | 6 million | 6/27/2019 | Jefferies, Cowen, BMO Capital Markets, Wells Fargo Securities |
| MorphoSys AG | MOR | $24.12-$24.12 | 8.3 million ADSs | 4/19/2018 | Goldman Sachs & Co., J.P. Morgan, Leerink Partners |
| Motus GI Holdings, Inc. | MOTS | $5.00-$7.00 | 3.5 million | 2/14/2018 | Piper Jaffray, Oppenheimer & Co. |
| MyoKardia, Inc. | MYOK | $15.00-$17.00 | 5.4 million | 10/29/2015 | Credit Suisse, Cowen & Co. |
| Myovant Sciences, Ltd. | MYOV | $12.00-$15.00 | 14.5 million | 10/27/2016 | Citigroup, Cowen and Company, Evercore ISI, Barclays |
| Nabriva Therapeutics AG | NBRV | $10.50-$10.50 | 9 million | 9/18/2015 | Leerink Partners, RBC Capital Markets |
| Nalu Medical, Inc. | NALU | TBD | TBD | 0/0/0 | JP Morgan, BofA Securities, William Blair |
| Nano-X Imaging Ltd. | NNOX | $16.00-$18.00 | 9.2 million | 8/21/2020 | Cantor, Oppenheimer & Co., Berenberg, CIBC Capital Markets
|
| NanoString Technologies | NSTG | $13.00-$15.00 | 5.4 million | 6/26/2013 | J.P. Morgan, Morgan Stanley |
| Nant Health | NH | $12.50-$15.50 | 6.5 million | 6/2/2016 | Jefferies, Cowen & Co. |
| NantKwest | NK | $20.00-$23.00 | 8.3 million | 7/28/2015 | BofA Merrill Lynch, Citigroup, Jefferies, Piper Jaffray |
| Natera, Inc. | NTRA | $15.00-$17.00 | 10 million | 7/2/2015 | Morgan Stanley, Cowen & Co., Piper Jaffray |
| Neon Therapeutics | NTGN | $15.00-$17.00 | 6.3 million | 6/27/2018 | Morgan Stanley, BofA Merrill Lynch, Mizuho Securities |
| Neos Therapeutics | NEOS | $14.00-$16.00 | 4.8 million | 7/23/2015 | UBS Investment Bank, BMO Capital Markets, RBC Capital Markets
|
| Neothetics, Inc. | NEOT | $13.00-$15.00 | 4.65 million | 11/20/2014 | Piper Jaffray, Guggenheim Securities
|
| Neumora Therapeutics, Inc.. | NMRA | $16.00-$18.00 | 14.7 million | 9/15/2023 | J.P. Morgan, BofA Securities, Stifel, Guggenheim, RBC Capital, William Blair
|
| Neuroderm, Ltd. | NDRM | $13.00-$16.00 | 4.5 million | 11/14/2014 | Jefferies, Cowen & Co. |
| Neuronetics, Inc. | STIM | $14.00-$16.00 | 5.5 million | 6/28/2018 | Piper Jaffray, William Blair |
| Neuropace Inc | NPCE | $15.00-$17.00 | 6 million | 4/22/2021 | JP Morgan, Morgan Stanley, Wells Fargo, SVB Leerink |
| Nevro | NVRO | $15.00-$17.00 | 7 million | 11/6/2014 | J.P. Morgan, Morgan Stanley |
| NewLink Genetics | NLNK | Last trade $11.40 | 3.5 million | 1/30/2013 | Jefferies, Stifel Nicolaus Weisel |
| NexImmune, Inc. | NEXI | $15.00-$17.00 | 6.5 million | 2/12/2021 | Barclays, Cantor, Raymond James, Allen & Co. |
| NextCure, Inc. | NXTC | $14.00-$16.00 | 5 million | 5/9/2019 | Morgan Stanley, BofA Merrill Lynch, Piper Jaffray |
| Nexvet Biopharma plc | NVET | $13.00-$16.00 | 4 million | 2/5/2015 | BofA Merrill Lynch, Cowen & Co. |
| NGM Biopharmaceuticals, Inc. | NGM | $14.00-$16.00 | 6.67 million | 4/4/2019 | Goldman Sachs, Citigroup, Cowen |
| Nightstar Therapeutics Limited | NITE | $13.00-$15.00 | 5.36 million ADSs | 9/28/2017 | Jefferies, Leerink Partners, BMO Capital Markets |
| Nivalis Therapeutics | NVLS | $13.00-$15.00 | 5.5 million | 6/17/2015 | Cowen & Co., Stifel |
| Nkarta, Inc. | NKTX | $16.00-$17.00 | 14 million | 7/10/2020 | Cowen, Evercore, Stifel, Mizuho |
| Novan, Inc. | NOVN | $11.00-$13.00 | 4.1 million | 9/21/2016 | Piper Jaffray |
| NovoCure Limited | NVCR | $26.00-$29.00 | 7.5 million | 10/2/2015 | J.P. Morgan, Deutsche Bank Securities, Evercore ISI |
| Nucana PLC | NCNA | $14.00-$16.00 | 6.67 million | 9/28/2017 | Citigroup, Jefferies, Cowen |
| Nurix Therapeutics, Inc. | NRIX | $17.00-$18.00 | 11 million | 7/24/2020 | JP Morgan, Piper Sandler, Stifel |
| Nuvalent Inc. | NUVL | $16.00-$18.00 | 9.8 million | 7/29/2021 | J.P. Morgan, Cowen, Piper Sandler |
| Nuvo Group Ltd. | NUVO | Withdrawn | Withdrawn | 0/0/0 | Cantor, Berenberg, Ladenburg Thalmann |
| NYXOAH SA | NYXH | $30.88-$30.88 | 2.835 million | 7/1/2021 | Piper Sandler, Stifel, Cantor
|
| Oak Street Health, Inc. | OSH | $19.00-$20.00 | 15.6 million | 8/6/2020 | J.P. Morgan, Goldman Sachs, Morgan Stanley, William Blair, Piper Sandler |
| Obalon Therapeutics | OBLN | $14.00-$16.00 | 5 million | 10/6/2016 | UBS Investment Bank, Canaccord Genuity, Stifel |
| ObsEva SA | OBSV | $14.00-$16.00 | 6.45 million | 1/26/2017 | Credit Suisse, Jefferies, Leerink Partners |
| Ocular Therapeutix | OCUL | $14.00-$16.00 | 5 million | 7/25/2014 | Morgan Stanley, Cowen & Co., RBC Capital Markets |
| Odonate Therapeutics, LLC | ODT | $24.00-$27.00 | 6.25 million | 12/7/2017 | Goldman Sachs, Jefferies |
| Odyssey Therapeutics, Inc. | ODTX | $16.00-$18.00 | 15.5 million | 5/8/2026 | J.P. Morgan, TD Cowen, Cantor |
| Olema Pharmaceuticals, Inc. | OLMA | $16.00-$18.00 | 11 million | 11/19/2020 | J.P. Morgan, Jefferies, Cowen, Canaccord Genuity ​ |
| Olink Holding AB | OLK | $16.00-$18.00 | 17.6 million | 3/25/2021 | Goldman Sachs, Morgan Stanley, SVB Leerink |
| Omada Health, Inc. | OMDA | $18.00-$20.00 | 7.9 million | 6/6/2025 | Morgan Stanley, Goldman Sachs, J.P. Morgan, Barclays, Evercore ISI |
| Omega Therapeutics Inc. | OMGA | $16.00-$18.00 | 7.4 million | 7/30/2021 | Goldman Sachs, Jefferies, Piper Sandler |
| Omthera Pharmaceuticals | OMTH | $12.00-$14.00 | 8 million | 4/11/2013 | BofA Merrill Lynch, Barclays Capital, Leerink Swann |
| Oncobiologics, Inc. | ONS | $6.00-$6.00 | 5.8 million | 5/13/2016 | Jefferies, Barclays |
| OncoMed Pharmaceuticals | OMED | $14.00-$16.00 | 4.8 million | 7/18/2013 | Jefferies, Leerink Swann |
| Onconova Therapeutics | ONTX | $12.00-$14.00 | 5.2 million | 7/25/2013 | Citigroup, Leerink Swann |
| Oncorus, Inc | ONCR | $14.00-$16.00 | 5.8 million | 10/2/2020 | Jefferies, Evercore ISI, Piper Sandler |
| Opgen, Inc. | OPGN | $8.00-$10.00 | 2.85 million | 5/5/2015 | Maxim Group LLC |
| Ophthotech Corporation | OPHT | $16.00-$19.00 | 2.28 million | 9/25/2013 | Morgan Stanley, J.P. Morgan |
| Opthea Limited | OPT | $17.26-$17.26 | 9.5 million ADSs | 10/16/2020 | Citigroup, SVB Leerink |
| Optinose, Inc. | OPTN | $15.00-$17.00 | 7.5 million | 10/13/2017 | Jefferies, Piper Jaffray, BMO Capital Markets, RBC Capital Markets |
| Orchard Rx Limited | ORTX | $14.00-$16.00 | 14.3 million ADSs | 10/31/2018 | J.P. Morgan, Goldman Sachs, Cowen |
| Oric Pharmaceuticals Inc. | ORIC | $14.00-$16.00 | 7.5 million | 4/24/2020 | J.P. Morgan, Citigroup, Jefferies, Guggenheim Securities |
| Orphazyme A/S | ORPH | $13.13-$13.13 | 7.6 million ADSs | 9/29/2020 | BofA Securities, Cowen, Guggenheim |
| Ortho Clinical Diagnostics Holdings plc | OCDX | $20.00-$23.00 | 76 million | 1/28/2021 | J.P. Morgan, BofA Securities, Goldman Sachs, Barclays, Morgan Stanley, Citigroup, Credit Suisse, UBS Investment Bank, Evercore ISI, Piper Sandler |
| OrthoPediatrics Corp. | KIDS | $12.00-$14.00 | 4 million | 10/12/2017 | Piper Jaffray, Stifel |
| Oscar Health, Inc. | OSCR | $36.00-$38.00 | 37.1 million | 3/3/2021 | Goldman Sachs, Morgan Stanley, Allen & Company, Wells Fargo Securities, BofA Securities, Credit Suisse |
| Osmotica Pharmaceuticals plc | OSMT | $14.00-$16.00 | 6.65 million | 10/18/2018 | Jefferies, Barclays, RBC, Wells Fargo |
| Otonomy, Inc. | OTIC | $14.00-$16.00 | 6.25 million | 8/13/2014 | J.P. Morgan, BofA Merrill Lynch |
| Outset Medical Inc. | OM | $22.00-$24.00 | 8.95 million | 9/15/2020 | BofA Securities, Morgan Stanley, Goldman Sachs, SVB Leerink, Stifel |
| Ovid Therapeutics Inc. | OVID | $15.00-$17.00 | 5 million | 5/5/2017 | Citigroup, Cowen and Company |
| Oxford Immunotec Global PLC | OXFD | $13.00-$15.00 | 5.36 million | 11/22/2013 | J.P. Morgan, Piper Jaffray |
| Oyster Point Pharma, Inc | OYST | $16.00-$18.00 | 5 million | 10/31/2019 | JP Morgan, Cowen, Piper Jaffray |
| PACS Group, Inc. | PACS | 21.4 million | $20.00-$22.00 | 4/11/2024 | Citigroup, J.P. Morgan, Truist |
| Pandion Therapeutics, Inc. | PAND | $16.00-$18.00 | 7.5 million | 7/17/2020 | Goldman Sachs, Morgan Stanley, SVB Leerink, BMO Capital Markets |
| Parabilis Medicines, Inc. | PBLS | $17.00-$19.00 | 33.5 million | 6/10/2026 | Leerink Partners, BofA Securities, Evercore ISI, Guggenheim Securities, LifeSci Capital |
| Paragon 28, Inc. | FNA | $15.00-$17.00 | 7.8 million | 10/15/2021 | BofA Securities, Piper Sandler |
| Parnell Pharmaceutical Holdings Ltd | PARN | $10.00-$10.00 | 5 million | 6/18/2014 | Jefferies, Piper Jaffray |
| Passage Bio, Inc. | PASG | $16.00-$18.00 | 12 million | 2/28/2020 | JP Morgan, Goldman Sachs, Cowen |
| Patheon N.V. | PTHN | $19.00-$22.00 | 29.76 million | 7/21/2016 | J.P. Morgan, Morgan Stanley, Jefferies, UBS Investment Bank,Credit Suisse, Evercore ISI, Wells Fargo Securities |
| Peloton Therapeutics, Inc. | PLTX | Withdrawn | Withdrawn | 5/23/2019 | JP Morgan, Citigroup, Jefferies |
| Penumbra, Inc. | PEN | $25.00-$28.00 | 4 million | 9/18/2015 | J.P. Morgan, BofA Merrill Lynch |
| PepGen Inc. | PEPG | $13.00-$15.00 | 9 million | 5/6/2022 | BofA Securities, SVB Leerink, Stifel |
| Personalis, Inc. | PSNL | $14.00-$16.00 | 7.92 million | 6/20/2019 | Morgan Stanley, BofA Merrill Lynch, Cowen |
| Perspectum Group plc | SCAN | Withdrawn | Withdrawn | 7/16/2021 | Citigroup, Barclays, Stifel, Canaccord Genuity
|
| PetIQ, Inc. | PETQ | $14.00-$16.00 | 6.25 million | 7/21/2017 | Jefferies, William Blair |
| Pfenex, Inc. | PFNX | $8.00-$8.00 | 8.33 million | 7/24/2014 | William Blair, JMP Securities |
| Pharvaris B.V. | PHVS | $17.00-$19.00 | 8.3 million | 2/5/2021 | Morgan Stanley, BofA Securities, SVB Leerink |
| PhaseBio Pharmaceuticals | PHAS | $12.00-$14.00 | 9.2 million | 10/18/2018 | Citigroup, Cowen, Stifel |
| PhaseRx, Inc. | PZRX | $5.00-$7.00 | 3.7 million | 5/18/2016 | Laidlaw & Co., Roth Capital Partners |
| Phathom Pharmaceuticals, Inc. | PHAT | $18.00-$20.00 | 9.6 million | 10/25/2019 | Goldman Sachs, Jefferies, Evercore ISI |
| Phibro Animal Health Corporation | PAHC | $16.00-$18.00 | 12.745 million | 4/11/2014 | BofA Merrill Lynch, Morgan Stanley, Barclays |
| Phreesia, Inc. | PHR | $15.00-$17.00 | 9.3 million | 7/18/2019 | JP Morgan, Wells Fargo Securities, William Blair, Allen & Co., Piper Jaffray |
| Pliant Therapeutics, Inc. | PLRX | $14.00-$16.00 | 9 million | 6/3/2020 | Citigroup, Cowen, Piper Sandler |
| PLX Pharma | PLXP | $17.00-$19.00 | 3.8 million | 0/0/0 | Raymond James, Maxim Group LLC |
| PMV Pharmaceuticals, Inc | PMVP | $16.00-$18.00 | 11.8 million | 9/25/2020 | Goldman Sachs, BofA Securities, Cowen, Evercore ISI
|
| PolyPid Ltd. | PYPD | $15.00-$17.00 | 3.8 million | 6/26/2020 | Barclays, BMO Capital |
| Portola Pharmaceuticals | PTLA | $13.00-$16.00 | 8.4 Million | 5/22/2013 | Morgan Stanley, Credit Suisse |
| Poseida Therapeutics, Inc. | PSTX | $16.00-$16.00 | 14 million | 7/10/2020 | BofA Securities, Piper Sandler, William Blair |
| PPD, Inc. | PPD | $24.00-$27.00 | 60 million | 2/6/2020 | Barclays, JP Morgan, Morgan Stanley, Goldman Sachs, BofA Securities, Credit Suisse, Jefferies, UBS Investment Bank, Citigroup, Deutsche Bank, Evercore ISI, HSBC, Mizuho Securities
|
| PRA Health Sciences, Inc. | PRAH | $20.00-$23.00 | 16.98 million | 11/13/2014 | Jefferies, Citigroup, KKR, UBS Investment Bank, Credit Suisse, Wells Fargo Securities
|
| Praxis Precision Medicines, Inc. | PRAX | $17.00-$18.00 | 10 million | 10/16/2020 | Cowen, Evercore ISI, Piper Sandler
|
| Precision BioSciences, Inc. | DTIL | $15.00-$17.00 | 7.9 million | 3/28/2019 | J.P. Morgan, Goldman Sachs & Co., Jefferies, Barclays |
| Prelude Therapeutics Incorporated | PRLD | $17.00-$19.00 | 8.3 million | 9/25/2020 | Morgan Stanley, Goldman Sachs, BofA Securities |
| Presbia PLC | LENS | $11.00-$13.00 | 4.2 million | 1/29/2015 | Jefferies |
| Press Ganey Holdings | PGND | $22.00-$24.00 | 8.9 million | 5/21/2015 | Barclays, Goldman Sachs & Co., William Blair, Wells Fargo Securities
|
| Prevail Therapeutics Inc. | PRVL | $16.00-$18.00 | 7.4 million | 6/20/2019 | Morgan Stanley, BofA Merrill Lynch, Cowen |
| Prime Medicine, Inc. | PRME | $16.00-$18.00 | 10.3 million | 10/20/2022 | J.P. Morgan, Goldman Sachs & Co., Morgan Stanley, Jefferies |
| Principia Biopharma Inc. | PRNB | $15.00-$17.00 | 6.3 million | 9/14/2018 | BofA Merrill Lynch, Leerink, Wells Fargo |
| Privia Health Group, Inc. | PRVA | $21.00-$23.00 | 19.5 million | 4/29/2021 | Goldman Sachs, JP Morgan, Credit Suisse, Piper Sandler, William Blair, Canaccord Genuity, Truist Securities |
| Progenity, Inc. | PROG | $14.00-$16.00 | 6.66 million | 6/19/2020 | Piper Sandler, Wells Fargo Securities |
| Progyny, Inc. | PGNY | $14.00-$16.00 | 10 million | 10/25/2019 | J.P. Morgan, Goldman Sachs & Co, BofA Merrill Lynch, Citigroup |
| Prolung, Inc. | LUNG | Withdrawn | Withdrawn | 0/0/0 | Maxim Group, Aegis |
| Prometheus Biosciences, Inc. | RXDX | $18.00-$19.00 | 10 million | 3/12/2021 | SVB Leerink, Credit Suisse, Stifel, Guggenheim Securities
|
| ProNAi Therapeutics | DNAI | $14.00-$16.00 | 8.1 million | 7/16/2015 | Jefferies, BofA Merrill Lynch |
| Proqr Therapeutics B.V. | PRQR | $11.00-$13.00 | 7.5 million | 9/18/2014 | Leerink Partners, Deutsche Bank Securities |
| Prosensa Holding B.V. | RNA | $11.00-$13.00 | 6 million | 6/28/2013 | J.P. Morgan, Citigroup, Leerink Swann |
| Protagonist Therapeutics | PTGX | $12.00-$12.00 | 7.5 million | 8/11/2016 | Leerink Partners, Barclays, BMO Capital Markets |
| Proteon Therapeutics, Inc. | PRTO | $12.00-$14.00 | 6.1 million | 10/22/2014 | Stifel, JMP Securities |
| Proteostasis Therapeutics | PTI | $12.00-$14.00 | 6.25 million | 2/11/2016 | Leerink Partners, RBC Capital Markets |
| Provention Bio, Inc. | PRVB | $4.00-$4.00 | 15.97 million | 7/24/2018 | MDB Capital Group |
| PTC Therapeutics | PTCT | $13.00-$16.00 | 8.4 million | 6/20/2013 | J.P. Morgan, Credit Suisse |
| Pulmonx Corporation | LUNG | $17.00-$18.00 | 10 million | 10/1/2020 | BofA Securities, Morgan Stanley |
| Pulse Biosciences | PLSE | $4.00-$4.00 | 5 million | 5/18/2016 | MDB Capital Group LLC, Feltl and Company |
| Pyxis Oncology, Inc. | PYXS | $14.00-$16.00 | 10.5 million | 10/8/2021 | BofA Securities, Jefferies, Credit Suisse, William Blair |
| Quanterix Corporation | QTRX | $14.00-$16.00 | 4.28 million | 12/7/2017 | J.P. Morgan, Leerink, Cowen |
| Quintiles Transnational | Q | $36.00-$40.00 | 23.7 million | 5/9/2013 | Morgan Stanley, Barclays, J.P. Morgan |
| Quotient Limited | QTNTU | $14.00-$16.00 | 5 million | 4/25/2014 | UBS Investment Bank, Baird, Cowen & Co. |
| Ra Medical Systems, Inc. | RMED | $14.00-$16.00 | 3.9 million | 9/27/2018 | Piper Jaffray, Cantor |
| RA Pharmaceuticals | RARX | $12.00-$14.00 | 7.05 million | 10/26/2016 | Credit Suisse, Jefferies, BMO Capital Markets |
| Radius Health | RDUS | $8.00-$8.00 | 6.5 million | 6/6/2014 | Jefferies, Cowen & Co. |
| Rain Therapeutics Inc. | RAIN | $16.00-$18.00 | 7.35 million | 4/23/2021 | Goldman Sachs, Citigroup, Piper Sandler, Guggenheim Securities |
| Rallybio Corporation | RLYB | $13.00-$15.00 | 6.2 million | 7/29/2021 | Jefferies, Cowen, Evercore |
| Rani Therapeutics Inc. | RANI | $14.00-$16.00 | 6.67 million | 7/30/2021 | BofA Securities, Stifel, Cantor, Canaccord Genuity |
| Rapid Micro Biosystems, Inc. | RPID | $18.00-$20.00 | 7.9 million | 7/15/2021 | JP Morgan, Morgan Stanley, Cowen, Stifel |
| Rapport Therapeutics, Inc. | RAPP | $16.00-$18.00 | 8 million | 6/7/2024 | Goldman Sachs, Jefferies, TD Cowen, Stifel |
| RAPT Therapeutics, Inc. | RAPT | $12.00-$14.00 | 3 million | 10/31/2019 | BMO Capital, Wells Fargo Securities, UBS Investment Bank |
| RayzeBio, Inc. | RYZB | $16.00-$18.00 | 17.3 million | 9/15/2023 | J.P. Morgan, Jefferies, Evercore ISI, Truist Securities |
| Realm Therapeutics plc | RLM | TBD | 5.07 million ADSs | 0/0/0 | TBD |
| Reata Pharmaceuticals | RETA | $14.00-$16.00 | 5.5 million | 5/26/2016 | Citigroup, Cowen & Co., Piper Jaffray |
| Receptos | RCPT | $14.00-$16.00 | 5.2 million | 5/9/2013 | Credit Suisse, Leerink Swann, BMO Capital Markets |
| Recursion Pharmaceuticals, Inc. | RXRX | $16.00-$18.00 | 24.2 million | 4/16/2021 | Goldman Sachs, JP Morgan, BofA Securities, SVB Leerink, Allen & Co. |
| REGENXBIO, Inc. | RGNX | $17.00-$19.00 | 6.3 million | 9/17/2015 | Morgan Stanley, BofA Merrill Lynch, Piper Jaffray |
| Regulus Therapeutics Inc. | RGLS | $10.00-$12.00 | 11.25 million | 9/7/2012 | Lazard Capital Markets, Cowen and Company, BMO Capital Markets
|
| Relay Therapeutics, Inc. | RLAY | $18.00-$19.00 | 20 million | 7/16/2020 | JP Morgan, Goldman Sachs, Cowen, Guggenheim Securities |
| Relypsa | RLYP | $16.00-$19.00 | 6.9 million | 11/15/2013 | Morgan Stanley, BofA Merrill Lynch |
| Renalytix AI plc | RNLX | $14.22-$14.22 | 5.5 million ADSs | 7/17/2020 | JP Morgan, Stifel |
| Reneo Pharmaceuticals, Inc. | RPHM | $15.00-$17.00 | 6.25 million | 4/9/2021 | Jefferies, SVB Leerink, Piper Sandler |
| Repare Therapeutics Inc. | RPTX | $16.00-$18.00 | 11 million | 6/19/2020 | Morgan Stanley, Goldman Sachs, Cowen, Piper Sandler |
| Replimune Group, Inc. | REPL | $14.00-$16.00 | 6.7 million | 7/20/2018 | J.P. Morgan, Leerink Partners, BMO Capital Markets |
| Restoration Robotics, Inc. | HAIR | $7.00-$9.00 | 3.57 million | 10/12/2017 | National Securities Corporation |
| resTORbio, Inc. | TORC | $14.00-$16.00 | 5.67 million | 1/26/2018 | BofA Merrill Lynch, Leerink Partners, Evercore ISI |
| Retension Pharmaceuticals, Inc. | RTSN | $11.00-$13.00 | 3.75 million | 10/9/2026 | Leerink Partners, Guggenheim Securities, Oppenheimer & Co., Titan Partners |
| Revance Therapeutics, Inc. | RVNC | $14.00-$16.00 | 6 million | 2/6/2014 | Cowen & Co., Piper Jaffray |
| Revolution Medicines, Inc. | RVMD | $16.00-$17.00 | 14 million | 2/13/2020 | JP Morgan, Cowen, SVB Leerink, Guggenheim |
| ReWalk Robotics Ltd. | RWLK | $14.00-$16.00 | 3 million | 9/12/2014 | Barclays, Jefferies |
| Rezera Inc. | RZRA | TBD | TBD | 0/0/0 | Jefferies, TD Cowen, Cantor, Wedbush PacGrow |
| Rhythm Pharmaceuticals, Inc. | RYTM | $14.00-$16.00 | 7.05 million | 10/5/2017 | Morgan Stanley, BofA Merrill Lynch, Cowen & Co. |
| Ritter Pharmaceuticals | RTTR | $5.00-$5.00 | 4 million | 6/24/2015 | Aegis Capital Corp, Chardan Capital Markets |
| Roka Biosciences | ROKA | $14.00-$16.00 | 5 million | 7/17/2014 | BofA Merrill Lynch, Leerink Partners |
| Rotech Healthcare Holdings, Inc. | ROTK | TBD | TBD | 0/0/0 | BofA Securities, Jefferies, UBS Investment Bank, Truist Securities, Baird, RBC Capital Markets |
| Royalty Pharma plc | RPRX | $25.00-$28.00 | 77.7 million | 6/16/2020 | JP Morgan, Morgan Stanley, BofA Securities, Goldman Sachs, Citigroup, UBS, Evercore ISI, Cowen, SunTrust Robinson Humphrey |
| Rubius Therapeutics, Inc. | RUBY | $20.00-$22.00 | 10.5 million | 7/18/2018 | J.P. Morgan, Morgan Stanley, Jefferies, Leerink Partners |
| RxSight, Inc. | RXST | $16.00-$18.00 | 7.35 million | 7/30/2021 | JP Morgan, BofA Securities, SVB Leerink, Wells Fargo Securities, BTIG
|
| Sage Therapeutics | SAGE | $17.00-$18.00 | 5 million | 7/18/2014 | J.P. Morgan, Goldman Sachs & Co. |
| Sagimet Biosciences Inc. | SGMT | $15.00-$17.00 | 5.3 million | 7/14/2023 | Goldman Sachs, Cowen, Piper Sandler |
| Sana Biotechnology, Inc. | SANA | $23.00-$24.00 | 23.5 million | 2/4/2021 | Morgan Stanley, Goldman Sachs, J.P. Morgan, BofA Securities |
| Sancilio Pharmaceuticals | SPCI | TBD | TBD | 0/0/0 | UBS Investment Bank, Piper Jaffray |
| Satsuma Pharmaceuticals, Inc. | STSA | $14.00-$16.00 | 5.5 million | 9/13/2019 | Credit Suisse, SVB Leerink, Evercore |
| Scholar Rock Holding Corporation | SRRK | $13.00-$15.00 | 5.4 million | 5/24/2018 | Jefferies, Cowen, BMO Capital |
| Schrodinger Inc. | SDGR | $14.00-$16.00 | 11.9 million | 2/6/2020 | Morgan Stanley, BofA Securities, Jefferies, BMO Capital Markets
|
| scPharmaceuticals, Inc. | SCPH | $14.00-$16.00 | 6.4 million | 11/17/2017 | Jefferies, Leerink, BMO Capital Markets |
| Scribe Therapeutics Inc. | SCTX | $13.00-$15.00 | 8.58 million | 7/24/2026 | Leerink Partners, Goldman Sachs, Guggenheim Securities, Wells Fargo |
| SCYNEXIS, Inc. | SCYX | $10.00-$10.00 | 6.2 million | 5/2/2014 | RBC Capital Markets, Canaccord Genuity |
| Seaport Therapeutics, Inc. | SPTX | $16.00-$18.00 | 14.2 million | 5/1/2026 | Goldman Sachs, J.P. Morgan, Leerink Partners, Citigroup, Stifel
|
| Second Sight Medical Products | EYES | $9.00-$9.00 | 3.5 million | 11/19/2014 | MDB Capital Group LLC |
| Seer, Inc. | SEER | $16.00-$18.00 | 9.2 million | 12/4/2020 | J.P. Morgan, Morgan Stanley, BofA Securities, Cowen |
| Selecta Biosciences | SELB | $14.00-$16.00 | 5 Million | 6/22/2016 | UBS Investment Bank, Stifel |
| SenesTech, Inc. | SNES | $12.00-$14.00 | 1.875 million | 12/8/2016 | Roth Capital Partners |
| Sensei Biotherapeutics, Inc. | SNSE | $16.00-$18.00 | 7 million | 2/4/2021 | Citigroup, Piper Sandler, Berenberg |
| Sensus Healthcare | SRTS | $6.25-$6.25 | 2 million | 6/3/2016 | Northland Capital Markets, Neidiger Tucker Bruner Inc |
| Septerna, Inc. | SEPN | $15.00-$17.00 | 16 million | 10/25/2024 | J.P. Morgan, TD Cowen, Cantor, Wells Fargo Securities |
| Sera Prognostics, Inc. | SERA | $15.00-$17.00 | 4.7 million | 7/15/2021 | Citigroup, Cowen, William Blair
|
| Seres Therapeutics | MCRB | $15.00-$17.00 | 7.43 million | 6/26/2015 | Goldman Sachs & Co., BofA Merrill Lynch |
| Shattuck Labs, Inc. | STTK | $14.00-$16.00 | 11.9 million | 10/9/2020 | Citigroup, Cowen, Evercore ISI |
| ShockWave Medical, Inc. | SWAV | $14.00-$16.00 | 5.7 million | 3/7/2019 | Morgan Stanley, BofA Merrill Lynch |
| Shoulder Innovations, Inc. | SI | $19.00-$21.00 | 5 million | 7/31/2025 | Morgan Stanley, Goldman Sachs, Piper Sandler, Jefferies
|
| SI-BONE, Inc. | SIBN | $13.00-$15.00 | 7.2 million | 10/17/2018 | Morgan Stanley, BofA Merrill Lynch |
| Sienna Biopharmaceuticals, Inc. | SNNA | $14.00-$16.00 | 4.33 million | 7/27/2017 | J.P. Morgan, Cowen, BMO Capital Markets |
| Sientra, Inc. | SIEN | $14.00-$16.00 | 5 million | 10/29/2014 | Piper Jaffray, Stifel
|
| Sight Sciences, Inc. | SGHT | $23.00-$24.00 | 10 million | 7/15/2021 | Morgan Stanley, BofA Securities, Citigroup, Piper Sandler |
| Sigilon Therapeutics, Inc. | SGTX | $17.00-$19.00 | 7 million | 12/4/2020 | Morgan Stanley, Jefferies, Barclays, Canaccord Genuity
|
| Signify Health, Inc. | SGFY | $20.00-$21.00 | 23.5 million | 2/11/2021 | Goldman Sachs, JP Morgan, Barclays, Deutsche Bank Securities, BofA Securities, UBS Investment Bank, Baird, Piper Sandler, William Blair |
| Silk Road Medical, Inc. | SILK | $15.00-$17.00 | 6 million | 4/4/2019 | JP Morgan, BofA Merrill Lynch |
| Silverback Therapeutics, Inc. | SBTX | $19.00-$20.00 | 11.5 million | 12/4/2020 | Goldman Sachs, SVB Leerink, Stifel |
| Singular Genomics Systems Inc. | OMIC | $20.00-$22.00 | 10.2 million | 5/27/2021 | JP Morgan, Goldman Sachs, BofA Securities, Cowen, UBS Investment Bank |
| Sionna Therapeutics, Inc. | SION | $16.00-$18.00 | 10.6 million | 2/7/2025 | Goldman Sachs, TD Cowen, Stifel, Guggenheim Securities
|
| Slide Holdings Insurance, Inc. | SLDE | $15.00-$17.00 | 24 million | 6/18/2025 | Barclays, Morgan Stanley, Citizens Capital Markets, Keefe Bruyette & Woods, Piper Sandler |
| SmileDirectClub, Inc. | SDC | $19.00-$22.00 | 58.5 million | 9/12/2019 | J.P. Morgan, Citigroup, BofA Merrill Lynch, Jefferies, UBS Investment Bank, Credit Suisse |
| Sol-Gel Technologies, Ltd. | SLGL | $11.00-$13.00 | 6.25 million | 2/1/2018 | Jefferies, BMO Capital Markets |
| Solid Biosciences Inc. | SLDB | $18.00-$19.00 | 7.5 million | 1/25/2018 | J.P. Morgan, Goldman Sachs & Co., Leerink Partners |
| Solta Medical Corporation | SLTA | Withdrawn | Withdrawn | 0/0/0 | Goldman Sachs, Morgan Stanley, Citigroup, Guggenheim Securities, Barclays, Evercore ISI |
| Sonendo, Inc. | SONX | $15.00-$17.00 | 7.8 million | 10/29/2021 | BofA Securities, Goldman Sachs, Piper Sandler, Stifel |
| SOPHiA GENETICS SA | SOPH | $17.00-$19.00 | 13 million | 7/23/2021 | J.P. Morgan, Morgan Stanley, Cowen, Credit Suisse |
| Sotera Health Company | SHC | $20.00-$23.00 | 46.6 million | 11/20/2020 | J.P. Morgan, Credit Suisse, Goldman Sachs, Jefferies, Barclays, Citigroup, RBC Capital Markets |
| Spark Therapeutics | ONCE | $15.00-$17.00 | 7 million | 1/30/2015 | J.P. Morgan, Credit Suisse |
| Spero Therapeutics, Inc. | SPRO | $14.00-$16.00 | 5.5 million | 11/2/2017 | BofA Merrill Lynch, Cowen & Company, Stifel |
| Spinal Elements Holdings, Inc. | SPEL | Postponed | Postponed | 10/15/2020 | Credit Suisse, Baird, Stifel |
| Spring Bank Pharmaceuticals | SBPH | $12.00-$14.00 | 0.92 million | 5/6/2016 | Dawson James Securities |
| SpringWorks Therapeutics, Inc. | SWTX | $16.00-$18.00 | 9.0 million | 9/13/2019 | JP Morgan, Goldman Sachs, Cowen |
| Spruce Biosciences, Inc. | SPRB | $14.00-$16.00 | 6 million | 10/9/2020 | Cowen, SVB Leerink, Credit Suisse, RBC Capital |
| SpyGlass Pharma, Inc. | SGP | $15.00-$17.00 | 9.375 million | 2/6/2026 | Jefferies, Leerink Partners, Citigroup, Stifel |
| SQZ Biotechnologies Company | SQZ | $16.00-$18.00 | 4.4 million | 10/30/2020 | BofA Securities, Stifel |
| SteadyMed Ltd. | STDY | $12.00-$14.00 | 4.7 million | 3/20/2015 | Wells Fargo Securities, RBC Capital Markets |
| Stealth BioTherapeutics Inc. | MITO | $12.00-$14.00 | 6.5 million ADSs | 2/15/2019 | Jefferies, Evercore, BMO Capital |
| Stemline Therapeutics | STML | $10.00-$12.00 | 3.3 million | 1/29/2013 | Aegis Capital Corp |
| Stevenato Group S.A. | STVN | $21.00-$24.00 | 32 million | 7/16/2021 | Morgan Stanley, BofA Securities, Jefferies, Citigroup, KeyBanc Capital, UBS Investment, Wells Fargo, William Blair |
| Stoke Therapeutics, Inc. | STOK | $14.00-$16.00 | 7.9 million | 6/19/2019 | JP Morgan, Cowen, Credit Suisse |
| Structure Therapeutics Inc. | GPCR | $13.00-$15.00 | 10.7 million | 2/3/2023 | Jefferies, SVB Securities, Guggenheim Securities, BMO Capital Markets |
| Surface Oncology, Inc. | SURF | $13.00-$15.00 | 7.2 million | 4/19/2018 | Goldman Sachs, Cowen, Evercore ISI |
| Surgery Partners, Inc. | SGRY | $23.00-$26.00 | 14.3 million | 10/1/2015 | BofA Merrill Lynch, Goldman Sachs & Co., Jefferies |
| Surgical Care Affiliates | SCAI | $21.00-$24.00 | 9.8 million | 10/30/2013 | J.P. Morgan, Citigroup |
| SurgiQuest, Inc. | TBD | TBD | TBD | 0/0/0 | Piper Jaffray, Stifel, Canaccord Genuity |
| Sutro Biopharma, Inc. | STRO | $14.00-$16.00 | 5.667 million | 9/27/2018 | Cowen, Piper Jaffray |
| Syndax Pharmaceuticals, Inc. | SNDX | $14.00-$16.00 | 4.4 million | 3/3/2016 | Morgan Stanley, Citigroup
|
| Synthorx, Inc. | THOR | $10.00-$12.00 | 11.9 million | 12/7/2018 | Jefferies, Leerink, Evercore ISI |
| Syros Pharmaceuticals | SYRS | $14.00-$16.00 | 4 million | 6/30/2016 | Cowen & Co., Piper Jaffray |
| T2 Biosystems, Inc. | TTOO | $15.00-$17.00 | 5.2 million | 8/7/2014 | Goldman Sachs & Co., Morgan Stanley |
| Tabula Rasa HealthCare | TRHC | $13.00-$15.00 | 4.3 million | 9/29/2016 | Wells Fargo Securities, UBS Investment Bank, Piper Jaffray |
| Tactile Systems Technology | TCMD | $14.00-$16.00 | 4 million | 7/28/2016 | Piper Jaffray, William Blair, Canaccord Genuity |
| Talaris Therapeutics, Inc. | TALS | $16.00-$18.00 | 8.8 million | 5/7/2021 | Morgan Stanley, SVB Leerink, Evercore ISI, Guggenheim Securities |
| Talis Biomedical Corporation | TLIS | $14.00-$16.00 | 13.8 million | 2/12/2021 | JP Morgan, BofA Securities, Piper Sandler |
| Tandem Diabetes Care | TNDM | $13.00-$15.00 | 8.0 million | 11/14/2013 | BofA Merrill Lynch, Piper Jaffray |
| Tarsus Pharmaceuticals, Inc. | TARS | $15.00-$17.00 | 5.5 million | 10/16/2020 | BofA Securities, Jefferies, Raymond James
|
| Taysha Gene Therapies, Inc. | TSHA | $18.00-$20.00 | 7.9 million | 9/24/2020 | Goldman Sachs, Morgan Stanley, Jefferies |
| TCR2 Therapeutics Inc. | TCRR | $14.00-$16.00 | 5 million | 2/14/2019 | Jefferies, SVB Leerink, BMO Capital |
| TELA Bio, Inc. | TELA | $14.00-$16.00 | 4 million | 11/8/2019 | Jefferies, Piper Jaffray, Canaccord Genuity |
| Teladoc, Inc. | TDOC | $15.00-$17.00 | 8.25 million | 7/1/2015 | J.P. Morgan, Deutsche Bank Securities |
| Tenaya Therapeutics, Inc. | TNYA | $14.00-$16.00 | 12 million | 7/30/2021 | Morgan Stanley, Cowen, Piper Sandler |
| Terns Pharmaceuticals, Inc. | TERN | $15.00-$17.00 | 7.5 million | 2/5/2021 | JP Morgan, Goldman Sachs, Cowen |
| Tesaro | TSRO | $12.00-$15.00 | 6.0 million | 6/28/2014 | Citigroup, Morgan Stanley, Leerink Swann |
| TetraLogic Pharmaceuticals | TLOG | $7.00-$7.00 | 7.2 million | 12/12/2013 | Oppenheimer & Co., Guggenheim Securities, Needham & Co. |
| Tetraphase Pharmaceuticals | TTPH | $10.00-$12.00 | 10.7 million | 3/20/2013 | Barclays, BMO Capital Markets |
| Thar Pharmaceuticals, Inc. | THAR | Withdrawn | Withdrawn | 0/0/0 | SunTrust Robinson Humphrey |
| The Joint Corp. | JYNT | $9.00-$11.00 | 3 million | 11/11/2014 | Roth Capital Partners, Feltl and Company
|
| Theseus Pharmaceuticals, Inc. | THRX | $14.00-$16.00 | 10 million | 10/7/2021 | Jefferies, SVB Leerink, Cantor |
| Third Harmonic Bio, Inc. | THRD | $16.00-$18.00 | 10.9 million | 9/15/2022 | Morgan Stanley, Jefferies, Cowen |
| Thorne HealthTech, Inc. | THRN | $10.00-$11.00 | 7 million | 9/23/2021 | BofA Securities, Cowen, Evercore ISI, RBC Capital Markets |
| Tocagen, Inc. | TOCA | $10.00-$12.00 | 8.5 million | 4/13/2017 | Leerink Partners, Evercore ISI, Stifel |
| Tokai Pharmaceuticals, Inc. | TKAI | $13.00-$15.00 | 6.48 miillion | 9/17/2014 | BMO Capital Markets, Stifel, William Blair |
| Tracon Pharmaceutical | TCON | $12.00-$14.00 | 3.6 million | 1/30/2015 | Wells Fargo Securities, Stifel |
| Translate Bio, Inc. | TBIO | $12.00-$14.00 | 9.4 million | 6/28/2018 | Citigroup, Leerink Partners, Evercore ISI |
| TransMedics Group, Inc. | TMDX | $15.00-$17.00 | 5.7 million | 5/2/2019 | Morgan Stanley, JP Morgan |
| Tranzyme | TZYM | $4.00-$4.00 | 13.5 million | 4/4/2011 | Citigroup |
| Treace Medical Concepts, Inc. | TMCI | $15.00-$17.00 | 11.25 million | 4/23/2021 | JP Morgan, Morgan Stanley |
| Trevena | TRVN | $7.00-$7.00 | 9.3 million | 1/31/2014 | Barclays, Jefferies |
| Trevi Therapeutics, Inc. | TRVI | $14.00-$16.00 | 5.5 million | 5/7/2019 | SVB Leerink, Stifel, BMO Capital |
| TRex Bio, Inc. | TRXB | $14.00-$16.00 | 8.34 million | 10/9/2026 | J.P. Morgan, Evercore ISI, Cantor, Stifel, Wedbush PacGrow |
| Tricida, Inc. | TCDA | $16.00-$18.00 | 11.7 million | 6/28/2018 | Goldman Sachs, J.P. Morgan, Cowen
|
| Trivascular Technologies, Inc. | TRIV | $13.00-$15.00 | 6.5 million | 4/16/2014 | J.P. Morgan, Credit Suisse |
| Trupanion Inc. | TRUP | $13.00-$15.00 | 7.1 million | 7/18/2014 | RBC Capital Markets, Barclays, Stifel |
| TScan Therapeutics, Inc. | TCRX | $15.00-$17.00 | 6.67 million | 7/16/2021 | Morgan Stanley, Jefferies, Cowen, Barclays |
| Turning Point Therapeutics, Inc. | TPTX | $16.00-$18.00 | 9.25 million | 4/17/2019 | Goldman Sachs & Co. LLC, SVB Leerink, Wells Fargo Securities |
| Turnstone Biologics Corp | TSBX | $12.00-$14.00 | 6.7 million | 7/21/2023 | BofA Securities, SVB Securities, Piper Sandler |
| Twist Bioscience Corporation | TWST | $14.00-$16.00 | 5 million | 10/31/2018 | J.P. Morgan, Cowen |
| Tyra Biosciences, Inc. | TYRA | $14.00-$16.00 | 10.8 million | 9/15/2021 | BofA Securities, Jefferies, Cowen |
| Ultragenyx Pharmaceutical | RARE | $14.00-$17.00 | 5.8 million | 1/31/2014 | J.P. Morgan, Morgan Stanley |
| Unicycive Therapeutics Inc. | UNCY | $5.00-$6.00 | 5 million | 7/13/2021 | Roth Capital |
| uniQure B.V. | QURE | $13.00-$15.00 | 5.4 million | 2/5/2014 | Jefferies, Leerink Swann, Piper Jaffray |
| Unity Biotechnology, Inc. | UBX | $16.00-$18.00 | 5 million | 5/3/2018 | Goldman Sachs & Co., Morgan Stanley, Citigroup |
| Unum Therapeutics, Inc. | UMRX | $12.00-$14.00 | 5.77 million | 3/29/2018 | Morgan Stanley, Cowen |
| Upstream Bio, Inc. | UPB | $15.00-$17.00 | 15 million | 10/11/2024 | JP Morgan, TD Cowen, Piper Sandler, William Blair |
| UroGen Pharma Ltd. | URGN | $12.00-$14.00 | 4.47 milliion | 5/4/2017 | Jefferies, Cowen and Company |
| Urovant Sciences Ltd. | UROV | $14.00-$16.00 | 10 million | 9/27/2018 | J.P. Morgan, Jefferies, Cowen |
| Vaccinex, Inc. | VCNX | $12.00-$15.00 | 3.3 million | 8/9/2018 | Oppenheimer & Co., BTIG |
| Vaccitech plc. | VACC | $16.00-$18.00 | 6.5 million ADSs | 4/30/2021 | Morgan Stanley, Jefferies, Barclays, William Blair |
| Valneva SE | VALN | $24.04-$28.85 | 2.3 million ADSs | 5/6/2021 | Goldman Sachs, Jefferies, Guggenheim Securities, Bryan Garnier & Co. |
| Vanguard Health Systems, Inc. | VHS | Priced at $18.00 | 25 million | 6/22/2011 | BofA Merrill Lynch, Barclays Capital, Citigroup, Deutsche Bank Securities, J.P. Morgan |
| Vapotherm, Inc. | VAPO | $14.00-$16.00 | 4 million | 11/14/2018 | BofA Merrill Lynch, William Blair |
| Vascular Biogenics, Ltd. | VBLT | $13.00-$15.00 | 6.66 million | 10/1/2014 | Deutsche Bank Securities |
| Vaxcyte, Inc. | PCVX | $14.00-$16.00 | 15.625 million | 6/12/2020 | BofA Securities, Jefferies, Evercore ISI |
| Vaxxinity, Inc. | VAXX | $14.00-$16.00 | 6 million | 11/11/2021 | BofA Securities, Jefferies, Evercore ISI |
| VectivBio Holding AG | VECT | $16.00-$18.00 | 7.5 million | 4/9/2021 | BofA Securities, SVB Leerink, Credit Suisse |
| Ventyx Biosciences, Inc. | VTYX | $15.00-$17.00 | 9.5 million | 10/21/2021 | Jefferies, Evercore ISI, Piper Sandler |
| Vera Therapeutics, Inc. | VERA | $14.00-$16.00 | 4.35 million | 5/14/2021 | Jefferies, Cowen, Evercore ISI |
| Veracyte, Inc. | VCYT | $13.00-$15.00 | 5 million | 10/30/2013 | Morgan Stanley, Leerink Swann |
| Veradermics, Incorporated | MANE | $14.00-$16.00 | 15.1 million | 2/4/2026 | Jefferies, Leerink Partners, Citigroup, Cantor |
| Verastem, Inc. | VSTM | $9.00-$11.00 | 5.5 million | 1/27/2012 | Jefferies, Leerink Swann |
| Verrica Pharmaceuticals Inc. | VRCA | $14.00-$16.00 | 5 million | 6/15/2018 | BofA Merrill Lynch, Jefferies, Cowen |
| Versartis, Inc. | VSAR | $16.00-$19.00 | 6 million | 3/21/2014 | Morgan Stanley, Citigroup |
| Verve Therapeutics, Inc. | VERV | $16.00-$18.00 | 14.035 million | 6/17/2021 | JP Morgan, Jefferies, Guggenheim Securities, William Blair |
| Viela Bio, Inc. | VIE | $19.00-$21.00 | 7.9 million | 10/3/2019 | Goldman Sachs, Morgan Stanley, Cowen
|
| Vigil Neuroscience, Inc. | VIGL | $15.00-$17.00 | 7 million | 1/7/2022 | Morgan Stanley, Jefferies, Stifel, Guggenheim Securities |
| Viking Therapeutics, Inc. | VKTX | $10.00-$12.00 | 3 million | 4/29/2015 | Laidlaw & Company (UK) Ltd. |
| Vir Biotechnology, Inc. | VIR | $20.00-$22.00 | 7.1 million | 10/11/2019 | Goldman Sachs, JP Morgan, Cowen, Barclays |
| Visterra, Inc. | VIST | $12.00-$14.00 | 3.9 million | 0/0/0 | Leerink Partners, Stifel |
| Vitae Pharmaceuticals, Inc. | VTAE | $11.00-$13.00 | 6.875 million | 9/24/2014 | Stifel, BMO Capital Markets |
| Vital Therapies | VTL | $13.00-$15.00 | 4.5 million | 4/17/2014 | BofA Merrill Lynch, Credit Suisse
|
| Viventia Bio, Inc. | VITA | TBD | TBD | 0/0/0 | Leerink Securites, Cowen and Company, Guggenheim Securities |
| Vividion Therapeutics, Inc. | VVID | Withdrawn | Withdrawn | 0/0/0 | JP Morgan, BofA Securities, Jefferies
|
| Vivos Therapeutics, Inc | VVOS | $5.00-$7.00 | 3.33 million ADSs | 12/11/2020 | Roth Capital |
| Vor Biopharma, Inc. | VOR | $16.00-$18.00 | 9.8 million | 2/5/2021 | Goldman Sachs, Evercore ISI, Barclays, Stifel |
| Voyager Therapeutics | VYGR | $15.00-$17.00 | 5 million | 11/11/2015 | Cowen & Co., Piper Jaffray, Nomura, Wedbush PacGrow |
| vTv Therapeutics Inc. | VTVT | $15.00-$17.00 | 7.8 million | 7/30/2015 | Piper Jaffray, Stifel |
| vVARDIS Holding AG | VVVV | TBD | TBD | 0/0/0 | Goldman Sachs, J.P. Morgan, William Blair, UBS Investment Bank, Deutsche Bank Securities, Apollo Global Securities |
| Wave Life Sciences PTE, Ltd. | WVE | $15.00-$17.00 | 6.375 million | 11/11/2015 | Jefferies, Leerink Partners |
| WCG Clinical, Inc. | WCGC | Postponed | Postponed | 8/5/2021 | Goldman Sachs, Morgan Stanley, BofA Securities, Barclays, Jefferies, William Blair, BMO Capital Markets, UBS Investment Bank, SVB Leerink HSBC |
| Werewolf Therapeutics Inc. | HOWL | $15.00-$17.00 | 7.5 million | 4/30/2021 | Jefferies, SVB Leerink, Evercore ISI |
| Windward Bio Group AG | WWB | TBD | TBD | 0/0/0 | Jefferies, TD Cowen, Piper Sandler, UBS Investment Bank |
| Xactly Corporation | XTLY | $10.00-$12.00 | 7.04 million | 6/26/2015 | J.P. Morgan, Deutsche Bank Securities, UBS Investment Bank |
| XBiotech, Inc. | XBIT | $18.00-$20.00 | 4 million | 4/15/2015 | WRHambrecht + Co. |
| Xenon Pharmaceuticals | XENE | $10.00-$12.00 | 4 million | 11/5/2014 | Jefferies, Wells Fargo Securities |
| Xeris Pharmaceuticals, Inc. | XERS | $14.00-$16.00 | 5.7 million | 6/21/2018 | Jefferies, Leerink Partners, RBC Capital, Mizuho Securities |
| Xilio Therapeutics, Inc. | XLO | $16.00-$18.00 | 7.35 million | 10/22/2021 | Morgan Stanley, Cowen, Guggenheim Securities |
| Y-mAbs Therapeutics, Inc. | YMAB | $14.00-$16.00 | 6 million | 9/21/2018 | BofA Merrill Lynch, Cowen, Canaccord Genuity |
| Zafgen, Inc. | ZFGN | $14.00-$16.00 | 6 million | 6/19/2014 | Leerink Partners, Cowen and Company
|
| Zai Lab Limited | ZLAB | $16.00-$18.00 | 8.0 million ADSs | 9/20/2017 | J.P. Morgan, Citigroup, Leerink Partners |
| Zealand Pharma A/S | ZEAL | $19.30-$19.30 | 4.375 million ADS | 8/9/2017 | Morgan Stanley, Goldman Sachs & Co. |
| Zenas BioPharma, Inc. | ZBIO | $16.00-$18.00 | 13.2 million | 9/13/2024 | Morgan Stanley, Jefferies, Citigroup, Guggenheim Securities |
| Zentalis Pharmaceuticals, LLC | ZNTL | $16.00-$18.00 | 9.18 million | 4/3/2020 | Morgan Stanley, Jefferies, SVB Leerink, Guggenheim Securities |
| Zoetis Inc. | ZTS | $22.00-$25.00 | 86.1 million | 2/1/2013 | J.P. Morgan, BofA Merrill Lynch, Morgan Stanley |
| Zosano Pharma Corporation | ZSAN | $10.00-$12.00 | 4.5 million | 1/27/2015 | Ladenburg Thalmann, Roth Capital Partners |
| ZS Pharma Inc., | ZSPH | $15.00-$17.00 | 5.9 million | 6/18/2014 | J.P. Morgan, Credit Suisse |
| Zymeworks Inc. | ZYME | $13.00-$16.00 | 4.5 million | 4/28/2017 | Citigroup, Barclays, Wells Fargo Securities, |
| Zynerba Pharmaceuticals, Inc. | ZYNE | $13.00-$15.00 | 3 million | 8/5/2015 | Jefferies, Piper Jaffray |
